Blog

Two important distinctions, as “PRODUCTS OF THE YEAR 2024”, were won by two significant products of the pharmaceutical company InterMed.

These are EVA INTIMA CERVASIL Granules and THE SKIN PHARMACIST – sensitive skin, which won this very high distinction in the country and stood out for their innovation and creative spirit, as consumer and useful products. In the sixth edition of the new era of the institution in Greece, products from 36 different categories managed to distinguish themselves and will be able to carry the “Product of the Year 2024” logo.

The awarding of the distinctions took place in a brilliant event in the packed Banquet Hall of the Athens Concert Hall, with business executives, representatives of institutional bodies and members of the academic community honoring the important evening with their presence.

As every year, the products that chose to participate in the institution were evaluated by an Expert Audit Committee, made up of trade professionals, representatives of institutional bodies and experts, in order to ensure that the criteria of innovation are met “Voted Product of the Year” is the largest and most important award institution internationally regarding the innovation of consumer products and services, with the distinctions resulting from a vote of the consumer public. It was founded in France in 1987 and is now organized in over 45 countries around the world, with the same main purpose: to highlight the new innovative products on the market and to reward the companies that create them, for their investment and belief in innovation.

UNI-PHARMA and InterMed- Tsetis pharmaceutical Group of companies-  won an important global distinction, as they were named TOP EMPLOYERS in Greece for the 2nd year in a row!

The companies, are the only Greek pharmaceutical companies to receive this distinction among 2,300 organizations in 121 countries. It is worth noting that the global and independent Top Employers Institute certifies organizations for HR Best Practices. The ceremony took place in Paris – Le Trianon – on January 23, 2024. The Top Employers program certifies organizations based on the participation and results of the HR Best Practices Survey. This survey covers six HR areas consisting of 20 topics including HR Strategy, Work Environment, Talent Acquisition, Training, Diversity, Equality and Inclusion, Wellbeing and more.

The Head of HR of UNI-PHARMA & InterMed Mrs Smaragdi Talaki, on the occasion of the important distinction, mentioned: “We are particularly satisfied with this global certification. The fact that we are, for the 2nd consecutive year, the first Greek pharmaceutical company to be recognized as a Top Employer fills us with optimism so that we can continue with our people to serve health and put human life as a priority. We are proud that a global independent organization recognizes the best practices of our companies and we are committed to continue working tirelessly to create an ever better environment for our 700 people.”

For his part, Top Employers Institute CEO David Plink states: “Great moments bring out the best in people and organizations. And that’s what we saw in the Top Employers certification program this year: outstanding performance from the certified Top Employers 2024. These employers have always shown that they care about the growth and well-being of their people. In this way, they collectively enrich the world of work. We are proud to announce and celebrate this year’s group of top people-oriented employers: Top Employers 2024.” The specific program certified and recognized 2,300 Top Employers from 121 countries on 5 Continents.

UNI-PHARMA SA, a pharmaceutical company of the Tsetis Pharmaceutical Group of companies, won an important distinction, which captures its developmental and economic sign in the country’s modern business and industrial production.

For one more year, on December 19, 2023, UNI-PHARMA SA emerged as a true industry leader, an ICAP assessment, receiving the ICAP TRUE LEADER title. In particular,

UNI-PHARMA was evaluated with this title, as: Included in the 500 most profitable Companies or 200 most profitable Groups for 2022 • It is among the 500 Companies or 150 Groups with the largest number of staff and having increased its staff from 2021 to 2022 • Ranked at the top of your Industry, based on Turnover • Has a high ICAP CRIF Credit Score.

The distinction was received by Mr. Athanasios Archontikis, Vice-Chairman of the Board of Directors of UNI-PHARMA SA.

The Hellenic Cardiology Society continues to inform the citizens as well as social actions to reduce mortality and morbidity resulting from cardiovascular diseases.

Specifically, on Friday, November 24, 2023, a team of cardiologists-members of the EKE, led by Mrs. Angeliki Mavroyianni, Member of the Board of Directors. of the Hellenic Cardiology Society, visited the Regional Clinic of Nestorius in Kastoria and performed a preventive cardiac check-up on approximately 70 people, most of them elderly.

During the examinations, the Doctors provided advice to the citizens, they were given informative material on the risk factors of cardiovascular diseases, while there were cases that were referred for further medical examination at the Kastoria Hospital. The President of EKE, Professor of Cardiology, Mr. G. Kochiadakis, on the occasion of this specific social action, stated: “The prevention of the cardiovascular health of citizens is the main concern of the Hellenic Cardiology Society, and in this context the initiative of EKE in Nestorio Kastoria, as well as other future actions in Attica and the region that are planned for the next period of time”.

The action was carried out with the kind sponsorship of the pharmaceutical industry UNI-PHARMA SA, within the framework of its Strategy for Sustainable Development and Corporate Responsibility

UNI-PHARMA SA, some weeks ago, won a significant distinction: the pharmaceutical company, distinguished as one of the 6th Growth Winners in Greece, among 8.000 companies, at the Growth Awards 2023, organized for the seventh year by Eurobank and Grant Thornton.

UNI-PHARMA SA, one of the six winners based on the evaluation carried out by the “Growth Awards” Awards Committee, was distinguished for its outstanding performance having been evaluated overall in a variety of important business and financial indicators.

The ceremony of GROWTH AWARDS 2023, which was jointly organized by Eurobank and Grant Thornton, took place in the “Christos Lambrakis” hall of the Athens Concert Hall, at November 1st, 2023.

The institution of the Growth Awards rewards the excellence of companies that combine high financial performance with a successful modern business history, contributing to the formation of a new landscape of entrepreneurship and work culture in the country.

The selection of the winners is made by extracting information from published financial statements, for more than 8,000 companies active in Greece, based on key financial indicators and strong quality characteristics.

The 20-member Awards Committee is jointly chaired by Mr. Georgios Zanias, Chairman of the Board of Directors of Eurobank SA and Mr. Vassilis Kazas, CEO of Grant Thornton, while prominent personalities from the Greek business and academic community participate as members:

The president and CEO of Tsetis Pharmaceutical Group of companies Mrs. Julia Tsetis, MSc pharmacist, Honorary Dr. of Pharmacy NKUA, General Secretary BoD of the BSE and President of the UN Global Compact Network Greece, was invited by the organizing Committee of the awards to take the stage, and after thanking EUROBANK and GRANT THORNTON, she emphasized, among other things: “It is a great honor to receive this award today, which highlights our tireless and sustained contribution to the challenging and competitive business environment. The GROWTH AWARDS are an important and reliable institution that supports Greek entrepreneurship. We trust the Greek entrepreneurship and of course we trust our employees.”

The Corporate Development Director of UNI-PHARMA SA, Spyros Kintzios, receiving with the CEO of Tsetis pharmaceutical group of companies Mrs Julia Tsetis the significant award GROWTH AWARD 2023, mentioned among others:

“The Tsetis group, which turns 60 years old this year, is resisting the constant challenges and difficulties, systematically investing in key production investments, actively participating in the digital transformation and principles of Sustainable Development, exporting dynamically to almost 70 countries under its own brand name- by UNI-PHARMA, and by InterMed- strengthening ethical partnerships with the academic and research community, supporting the environment and empowering vulnerable social groups. And all this, with the strength and the support of the Tsetis Group’s 700 employees”.

InterMed SA won two important distinctions, in the context of the PACKAGING AWARDS 2023, on September 27, 2023, at the Sofitel Athens Airport in Athens.

The two awards won by InterMed, of the Tsetis Pharmaceutical Enterprises Group, are:

5.3 Reusable | Recyclable package- Bronze, for UNIDENT KIDS TOOTHPASTES – Ethical practices in InterMed’s packaging and

5.3 Reusable | Recyclable package – Silver, for LUXURIOUS SUN CARE: We give a second life to our sunscreens.

In their seventh edition, the BOUSSIAS events awards, in collaboration with the Association of Materials Production and Packaging Industries, reward businesses that have managed to convey the true value of packaging in product branding. The evaluation committee highlighted the top packaging of the year for innovation, design, technologies, materials, but also public preference, effectively outlining the dominant trends in packaging today.

 

Four awards which underline the crucial role of the industry in the pharmacy channel, as well as an honorary distinction from EXELIXI ZOIS (LIFE DEVELOPMENT), strengthen even more the commercial and above all the social role of the Tsetis Pharmaceutical Group of companies.

On September 7, 2023, at a special charity dinner at the GAIA Center of the Goulandris Museum of Natural History, the president and CEO of OFET pharmacist MSc, Emeritus Dr. of Pharmacy of UNKA, General Secretary of the Board of Directors of SEV  and President of UN Global Compact Net Work Greece Mrs. Julia Tsetis, received an honorary award from the EXELIXI ZOIS, organization. It is a Social Agency, which aims to support, social and work reintegration and autonomy of teenagers (16-18 years old) and young adults (18-25 years old), who come from institutional care environments through programs of educational training, psychosocial empowerment and the their participation in sports and cultural activities.

BEST IN PHARMACY & SUPPLEMENT AWARDS 2023

In addition, four awards, which highlight the significant role of InterMed and its products in the pharmacy channel, were received by the Greek pharmaceutical industry on Tuesday, September 12, 2023, in the framework of the Best In Pharmacy Awards and Supplement Awards 2023, organized by the BOUSSIAS group.

In detail, the awards received by InterMed SA are as follows:

1.1 Best Facial/Serum Innovative Deep Hydration Serum – The Skin Pharmacist Philosophy

2.15 Best repackaging Luxurious Sun Care: Relaunch with friendly & sustainable packaging

1.6 Best Product for Women Eva Intima Cervasil Granules – Nutritional supplement for HPV clearance.

At the SUPPLEMENT AWARDS, InterMed was distinguished with D3 fix drops: New generation of supplements with high absorption in the form of mycelia, in category 4.7 Best Reformulation.

Another important award has been added to the portfolio of Tsetis Pharmaceutical Group of companies, from the event ceremony of the PROTAGONISTS OF THE GREEK ECONOMY 2023. The distinction, in particular, concerns the business extroversion of UNI-PHARMA SA.

The real success stories of Greek business were honored at the Awarding Ceremony of the awards-institution for Greek business, “Protagonists of the Greek Economy 2023”, organized for the eighth time by Direction Business Network, on Monday, July 17, 2023.

At Golf Privé in Glyfada, in the presence of more than 550 high-ranking business executives and representatives of the academic world, companies and, of course, their people were rewarded, which manage to overcome any difficulty and significantly support their industries and the domestic economy as a whole, as well as develop and make progress.

The prizes awarded are based on the official financial data of the companies as reflected in their financial reports and are presented in detail in the luxurious 10th edition “The Powers of the Greek Economy” by Direction Business Network, which has just been released.

The prize was received by UNI-PHARMA & InterMed’s Export manager, Mr. Gorgos Spigos. The event ceremony, was under the auspices of the Ministry of Development.

Two awards, which underline UNI-PHARMA & InterMed’s continuous dedication to Ethical Business, fruitful collaborations with the academic and research community and sustainable entrepreneurship, were won by the pharmaceutical companies – of the Tsetis Pharmaceutical Group of companies, during the HELLENIC RESPONSIBLE AWARDS 2023, organized by Boussias Group on July 12, 2023.

This is the SILVER award in category 1.4 Cooperation of Business & Academic Bodies OFET – Business ethics & support for the new generation of researchers and the award BRONZE, in category 6.9 “Green” Buildings / Built Environment – The green buildings of UNI-PHARMA & InterMed, model of Sustainable Development.

The institution of the Hellenic Responsible Business Awards, for the eighth consecutive year, rewarded companies that promote the values of Sustainable Entrepreneurship, investing in Sustainable Environmental and Social Development. The award ceremony took place on Wednesday, July 12, 2023, at the Wine Museum, under the auspices of the Ministry of Development and Investments, the Ministry of Environment and Energy and the BSE, as well as with broad institutional honorary support, while the greeting of the event was carried out by the Deputy Minister of Development and of Investments, Mr. Maximos Senetakis.

 

Two Bronze Awards, which demonstrate UNI-PHARMA & InterMeds tireless efforts to holistically serve the Health & Safety at Work model across all facilities, protecting at the same time all the employers equally, were received by the two industries during the Health & Safety Winners Awards Ceremony Awards 2023.

The event took place at the Hellenic Cultural Foundation on Thursday, June 8, 2023 at 8:30 p.m. The Health & Safety Awards 2023 were organized for the 9th year by BOUSSIAS under the auspices of the Hellenic Institute of Occupational Health and Safety.

The two Bronze awards concern:

3.9. Preventing the Spread of Covid-19 OFET – Effective solutions in the pandemic & post-Covid era

5.1. Innovation in Occupational Health & Safety UNI-PHARMA: Digital technologies that lead to prevention

Three significant awards- two Silver and one Bronze- were received by UNI-PHARMA & InterMed industries, on May 18, 2023, the ENERGY MASTERING AWARDS.

These are the unique awards related to energy management and business sustainability that highlighted the winners, in a difficult and demanding year that tested the endurance of systems and people!

The aim of the Energy Mastering Awards 2023, organized for the 5th year by BOUSSIAS Events, is to recognize the companies, organizations and providers of related services and solutions that have demonstrated an excellent track record in achieving a high level of energy management standards and are committed to future improvement and sustainable development .

The Chairman of the Jury, Dr. Giorgos Ageridis, former Director of Energy Efficiency, Center for Renewable Sources and Energy Saving (KOPE) sent a congratulatory message to the winners, encouraging them to continue their work with the same momentum and creativity,

On the map of “The Most Sustainable Companies in Greece 2023” the Tsetis Pharmaceutical Group of companies was distinguished for another year, after a thorough evaluation, committed to issues of sustainability and responsible business.

A commitment which is a culture and at the same time a philosophy for the more than 600 employees of the Tsetis Group.

OFET participated in the Sustainability Performance Directory 2023 initiative of the Quality Net Foundation Organization and was named among the 35 leading companies, which create the business map of sustainable development in the country, based on the evaluation of their corporate business performance on three criteria: Environment – Society – Corporate Governance (ESG).

For Tsetis Pharmaceutical Group of companies, sustainability is a holistic concept, linked to long-term environmental, economic and social benefits by taking care of the needs of present and future generations.

In particular, in the Group’s industries, the environmental and energy balance is controlled, with a simultaneous reduction of the carbon footprint, limiting the appeal of greenhouse gases and converging towards the goal of climate neutrality.

The “MOST SUSTAINABLE COMPANIES” award was received on Thursday, March 30, 2023 at the Goulandris Museum of Natural History by Mr. Spyros Kintzios, Director Corporate Development of UNI-PHARMA, who referred to the value but also to the one way of sustainable development and responsible entrepreneurship for the modern businesses.

Three very significant awards, which capture and seal the relationship of the Tsetis Pharmaceutical Group of companies with the pharmacists, were received by UNI-PHARMA & InterMed industries, in the context of the PHARMACEUTICAL MARKET EXCELLENCES 2023 (ARISTEIA), on Wednesday, April 26, 2023.

The 2023 Pharmaceutical Market Excellence Award ceremony, organized by Noufio Communication Services since 2017, took place at the  Zappeion Megaro.

For the sixth year, excellence was awarded to businesses, agencies and groups, for action, actions, presentation of innovations or best practices for the benefit of pharmaceutical care, prevention and the operation of pharmacies.

In detail, the awards received by OFET’s pharmaceutical companies are as follows:

01 Corporate social responsibility in the pharmaceutical market

Gold: UNI-PHARMA

The award was received by Mrs. Smaragdi Talaki, HR & CSR of Tseti Pharmaceutical Enterprises Group.

06 Innovative product in the pharmacy

Gold: UNI-PHARMA for APOTEL ESPRESSO

The award was received by Mrs. Angeliki Oikonomou, OTC Product Manager of UNI-PHARMA.

12 Sales team distinguished in pharmacies

Platinum: INTERMED

The award was received by Mr. Antonios Zeppos, Commercial Director of InterMed & Pharmabelle.

Honorary Award as “Honourable Pharmaceutical Innovation Company” was received by the Tsetis Pharmaceutical Group of Companies, led by the president and CEO of the Group Mrs. Julia Tsetis, for its development and contribution to the Greek economy, in the framework of the PRIX GALIEN 2023 awards, on April 5 2023, at the Concert Hall.

The honorary distinction was presented to Mrs. Tseti by the Minister of Labor & Social Affairs, Kostis Hatzidakis. As Mrs. Iulia Tseti – MSc pharmacist, Emeritus Dr. pointed out in her speech. Pharmacist of EKPA, CEO of the Board of Directors of SEB and president of the UN Global Compact Network Hellas – “The Tseti Group is intertwined with the concepts of innovation, responsible entrepreneurship, sustainable development, excellence, equal opportunities at work and in positions of responsibility, no gender environment and gender equality.

The Tsetis Group, is not afraid of excellence and this philosophy has been fully embraced by the more than 600 employees of the Group. The industries of OFET, UNI-PHARMA & InterMed, are internationally recognized as official suppliers of the United Nations, UNICEF and the World Health Organization, while recently we were distinguished as MOST SUSTAINABLE COMPANIES and also as Top Employers, through continuous and rigorous evaluations.

Three very important awards – two GOLD and one BRONZE, were received on March 21, 2023 by the team of Tsetis Pharmaceutical Group of companies, within the GREEN BRAND AWARDS of the Boussias Group.

For the 3rd year in a row, excellence and innovation in products, services and development processes that promote the GREEN economy and Eco Living were highlighted and rewarded. In total, 64 companies, institutions and natural persons from a wide range of business activity were distinguished in all categories of the awards.

For her contribution to modern Women’s Entrepreneurship, Mrs. Julia Tsetis, MSc pharmacist, president and CEO of the Group Honorary Dr. Faculty of Pharmacy of EKPA, president of the United Nations Global Compact Network Hellas and Secretary General of the Board of Directors of SEV, in the context of the 2nd WOMEN’S Conference on “CONTERN WOMEN//SUCCESSFUL MANAGERS”, organized by the Business Review Magazine.

The conference was held under the auspices of EBEA, GENERAL SECRETARIAT OF DEMOGRAPHICS & FAMILY POLICY & EQUALITY OF LEAVES, EGE, HELLA-DICA MAS. The event took place at ACCI -Athens Chamber Commerce & Industry- and the award was received by Mr. Athanasios Archontikis – Operations Director, Pharmacist, MBA, Vice President of UNI-PHARMA.

The topics developed at the conference were: “The Food Industry in the “services of the modern woman” “Women marketers” “Startups and women’s entrepreneurship” “Navigating DIGITAL MARKETING as a female entrepreneur” “Women’s entrepreneurship in the Fast-Moving Products market” “Successful Managers in companies that stand out” “The combination of family and professional obligations in modern reality” “Women Managers – Or Not?” “The Role of Women in Modern Merchant Shipping” T

he conference was attended by the Deputy Minister of Labor and Social Affairs Maria Syregela, the Deputy Minister of Immigration and Asylum Sofia Voultepsi and the former Minister and Member of Parliament for the North of Athens Giorgos Koumoutsakos. A total of 12 female entrepreneurs, politicians and journalists were awarded for their work.

 

The Tsetis pharmaceutical Group of companies UNI-PHARMA & InterMed were declared Top Employers in Greece for 2023 by the Top Employer Institute.

The certification by the independent international organization “Top Employer” proves the organization’s commitment to a better working environment through the policies and good practices of the Human Resources department.

The Top Employers program certifies organizations based on the participation and results of the HR Best Practices Survey. This survey covers six HR areas consisting of 20 topics including HR Strategy, Work Environment, Talent Acquisition, Training, Diversity, Equality and Inclusion, Wellbeing and more.

The Head of HR of UNI-PHARMA & InterMed Smaragdi Talaki said: We are particularly pleased with this global certification. The fact that we are the first Greek pharmaceutical company to be recognized as a Top Employer for 2023 fills us with optimism to continue with our people to serve health and put human life as a priority. We are proud to have our companies’ best practices recognized by a global independent organization and are committed to continuing to work tirelessly to create an ever better environment for our 600 people.

For his part, Top Employers Institute CEO David Plink states: “Great moments bring out the best in people and organizations. And that’s what we saw in the Top Employers certification program this year: outstanding performance by certified Top Employers 2023. These employers have always shown that they care about the growth and well-being of their people. In this way, they collectively enrich the world of work. We are proud to announce and celebrate this year’s group of top people-oriented employers: Top Employers 2023.”

The specific program certified and recognized 2,053 Top Employers from 121 countries on 5 Continents.

About UNI-PHARMA & InterMed

The Tseti Pharmaceutical Enterprises Group consists of the pharmaceutical companies UNI-PHARMA and InterMed, the medicinal plant extraction unit UniHerbo in Greece and the trading company in Cyprus Pharmabelle. The industries, with their pioneering and innovative formulations, are the most reliable ambassadors of our country and Greek production in the 66 foreign markets. The Group has adopted the SDGs and Sustainable Development standards as an integral part of its daily operation. The management of the Group aims to increase even more its social footprint, while reducing the environmental and energy footprint, remaining committed to effective corporate governance and Ethical Business. In recent years, OFET has invested more than €80 million, while in the three-year period 2019-2021 the investments exceeded €50 million. In the last four-year period 2018-2021, it financed a total of 37 research proposals with its own funds – of which 20 concern scholarships of the AMKE “Kleon Tsetis” Foundation.

For more information: www.uni-pharma.gr

About the Top Employers Institute

The Top Employers Institute is the global authority for recognizing excellence in Human Practices. The Institute helps accelerate these practices to enrich the world of work. Through the Top Employers Institute Certification Program, participating companies can be validated, certified and recognized as an “employer of choice.” Founded more than 30 years ago, the Top Employers Institute has certified 2,053 organizations in 121 countries/regions. These certified top employers positively impact the lives of more than 9.5 million workers worldwide.

After a two-year forced absence due to the pandemic, AMKE’s “Diabetes-Driven Magic Bus” returned just before Christmas 2022, and InterMed was there to support it.

The message of InterMed- company of OFET (Tsetis Pharmaceutical Group of companies) and also of the Magic Diabetes Bus, which went out in the streets and squares of Attica, was about informing and raising awareness among people with diabetes.

InterMed participated with the Diabetel series for the diabetic foot and with the Slim fix formulation – liquid sweetener with stevia.

From December 18 to 23, 2022, the Christmas decorated bus – Magic Diabetes Bus, transformed into a fairytale, informed, but also entertained young and old who visited it.

As well the adults and seniors, had the opportunity to measure their glucose, learn about diabetes and vaccination and have their questions answered by the scientific team consisting of a diabetologist, nutritionist and podiatrist. We should not forget that patients with Diabetes are much more vulnerable to infections than their healthy peers.”

UNI-PHARMA SA won two important Awards, just before the end of the year, which rank it very high in the competitive business field.

These significant awards, are the DIAMONDS OF THE GREEK ECONOMY & ICAP – TRUE LEADERS 2022 awards. UNI-PHARMA SA, an industry of the Tsetis Pharmaceutical Group of companies, was distinguished for its dynamic financial results.

In particular, regarding ICAP – TRUE LEADERS, we should note that ICAP CRIF, the only company recognized as a Credit Rating Agency by the Capital Market Commission and the corresponding European competent authority (European Securities and Markets Authority), has been awarding since 2011 the Companies and Clubs that meet, based on published results, the following criteria:

• Included in the 500 most profitable Companies or in the 200 most profitable Groups

• Are among the 500 Companies or 150 Groups with the largest number of staff and have increased their staff

• They are at the top of their Industry based on Turnover

• They have a high ICAP CRIF Score.

UNI-PHARMA SA meets all the above criteria and despite the forecasts for a difficult 2023, due to inflationary pressures, the energy crisis and the ongoing war in Ukraine, it is optimistic for even more positive results.

UNI-PHARMA InterMed, companies of Tsetis Pharmaceutical Group of companies, won four important awards- two Silver, one Bronze and one Winner- related to ESG (Environment, Society, Governance) strategy, environmental & energy policy and operational Ethics & Corporate Social Responsibility, at the Manufacturing Excellence Awards 2022, organized by Boussias group, on November 1st, 2022.

The awards were organized for the 4th year by Boussias in collaboration with Manufacturing Magazine and Industry News Daily!

The Manufacturing Excellence Awards in particular highlight and reward actions and projects of businesses for strong resilience and timely adaptability to new production, distribution and communication conditions, digital and green transformation, human resource development and their contribution to the development of the national economy .

The awards were received by Mrs. Elena Alexia Kyriakopoulou – Energy Environmental Health & Safety Manager of OFET and Mr. Manos Nikitakis, engineering Validation Engineer OFET – Tsetis Pharmaceutical Group of companies.

With five awards, which highlight the crucial role in fields of smart waste management, circular economy, energy reduction, ecological and environmental label, UNI-PHARMA & InterMed were distinguished at the Enviromental Awards 2022 organized by Boussias group.

The awards that highlight and reward good practices and initiatives for the protection of the Environment and Sustainability, as well as innovative “green” projects, technologies or programs, announced the winners on Wednesday, September 28 at the Hellenic Cultural Foundation.

In detail, the awards with which UNI-PHARMA & InterMed were distinguished are as follows:

GOLD for the Bioclimatic facilities of UNI-PHARMA S.A.

SILVER for smart waste management at OFET Group

SILVER also for the Integrated environmental and energy management system at OFET – Tsetis Pharmaceutical Enterprises Group.

BRONZE for actions related to sustainability, circular economy and innovation

And one more BRONZE, for OFET’s actions, with an environmental and ecological mark.

The iconic Greek island of light, Delos, was chosen for second year by the Tsetis Pharmaceutical Group of companies with the companies UNI-PHARMA & InterMed, for the voluntary action of coastal and underwater cleaning that took place on Saturday, September 3, 2022.

This year we collaborated with the V GROUP Group of companies, under the auspices of the Municipality of Mykonos and the support of the Mykonos Port Authority, the Ephorate of Antiquities of the Cyclades and the Ephorate of Marine Antiquities.

The dynamic volunteer groups of the OFET & V Group, jointly embracing the values ​​of social contribution and environmental protection, cleaned the beaches of the island of waste, while experienced groups of divers engaged in the collection and removal of waste from the bottom of the sea of the island. The collected waste from the two cleaning actions was collected in special transport packages and taken for management to the modern facilities of the V GROUP Group.

The significant initiative of the two Groups is the result of wider cooperation on the basis of common corporate values, goals and mission related to the promotion of sustainable development, the adoption of the principles of the circular economy, the full utilization of waste (zero waste), as well as the offer to society to ensure sustainability for future generations.

Deeply aware of the responsibility they bear towards the natural and social environment in which they operate, the OFET & V GROUP Groups of companies have long experience in the development of voluntary actions with the participation of a large number of employees, who embrace the Groups’ actions for the benefit of sustainable development and social contribution, acting as a role model for the wider professional and social environment, which they wish to positively influence and inspire with their philosophy and actions.

Mrs Smaragdi Talaki, Head of HR and CSR of OFET Group, mentioned about the action: “Cooperation is a key pillar for sustainable development and the joy is greater when we cooperate with companies like V Group in such voluntary actions. At UNI-PHARMA and InterMed we are all committed to serving health with passion, creativity and ethics, because human life is our biggest priority. We are constantly looking for innovative medical care solutions, contribute to improving the quality of life and work hard to prevent and treat diseases of modern man. At the same time, we are proud of our ongoing and tireless actions aimed at supporting vulnerable groups in society, science, the new generation and the environment.”

Mrs Natassa Triantafyllidou, Climate Change & Sustainability Manager of the V GROUP, mentioned in this regard: “We are particularly happy for the cooperation with the OFET Group and the success of the voluntary action which is only the beginning of a series of joint actions for the offer to society as a whole and in the natural environment. As a model environmental and energy Group, V GROUP directly links its development with sustainability and implements actions that promote the principles of rational waste management and circular economy, as they are consistent with its vision of creating a legacy of values ​​that they will inspire and motivate future generations to strive for sustainable development while maintaining intact respect for the environment.”

Three significant awards – one for Responsible Leadership and two environmental – were received by the Tsetis Pharmaceutical Group of companies (OFET) at the Hellenic Responsible Business Awards 2022 organized by the Boussias group.

In particular, on July 13, 2022, the president and CEO of the Tsetis Pharmaceutical Enterprises Group, MSC pharmacist, Honorary Doctor of Pharmacy of EKPA, president of the UN Global Compact Network Hellas and General Secretary of SEV, Julia Tseti, received the “Responsible Leader” award. At the same ceremony, OFET’s two industries, UNI-PHARMA and InterMed, received two important awards, one Gold for effective waste management and one Bronze, for the Group’s zero waste strategy.

At the event, the Minister of Development and Investments, Adonis Georgiadis, as well as the Director General of the BSE, Mr. Alexandros Hatzopoulos, addressed a greeting.

The institution of the Hellenic Responsible Business Awards, for the seventh consecutive year, awarded companies that promote the values ​​of Responsible Entrepreneurship and invest in Sustainable Environmental and Social Development.

The award ceremony took place on Wednesday, July 13, 2022, at the “Hellenic World” Cultural Center in a glittering evening under the patronage of the Ministry of Development and Investments, the Ministry of Environment and Energy and the SEV, as well as with wide institutional honorary support.

With three important awards, the pharmaceutical companies UNI-PHARMA and InterMed were distinguished, in the context of the Great Celebration of Production in Greece, “Made in Greece Awards 2022” on Monday, June 20 at Zappeio Megaron.

Manufacturing companies, which operate in our country and achieve excellent performance in the creation and distribution of products, and which continue to invest in our country by creating added value, were awarded at the “Made in Greece Awards 2022” Awards Ceremony.

The Tsetis Pharmaceutical Enterprises Group was distinguished overall in the following fields:

Export Excellence Award

INTERMED SA – BRONZE

Innovative Consumer Product Award

INTERMED SA (SOLUMAG SAFRRON WITH CURCUMIN) – BRONZE

Sustainable Development Award

UNI-PHARMA SA – BRONZE.

The event, which has been recognized since 2013 as the great celebration of production in Greece, was organized by the Hellenic Academy of Marketing.

 A new significant environmental action with the motto “Keep Paros Blue” was implemented on Saturday, June 25, 2022, by the Tsetis Pharmaceutical Group of Companies and the Organization All For Blue.

The action – during which the municipal authority was also present, specifically the Mayor Mr. Markos I. Kovaios – included a coastal and an underwater cleanup at Livadia beach of Paros.

Approximately 30 executives of the Tsetis Pharmaceutical Group of Companies (OFET) as members of the group’s Green Team, 7 small volunteers – members of the Naval Club of Paros (NOP), 8 scuba divers, 4 free divers from the local diving centers Paros Diving Center and Cycladic Diving as well as members of All For Blue worked together to restore the beach. The result of the cleanup, which was carried out using All For Blue’s zero footprint protocol, was the removal of dozens of aluminum soda cans from the beach bed and the simultaneous release of four small octopuses from the cans.

Food packaging, plastic water bottles, disposable cups, cardboard boxes, straws, etc. were also collected. All these objects were registered in the Padi Aware database with reference to OFET.

This environmental action is part of the Strategy of the Tsetis Pharmaceutical Group of Enterprises for Sustainable Development and Accountability, at the core of which is the support of vulnerable groups in society, the strengthening of research and the new generation and the protection of the environment and ecosystem. In September 2021, OFET’s Green Team had carried out a corresponding environmental action on the emblematic island of Delos.

Mrs. Ioulia Tseti, MSc Pharmacist, President and CEO of the Tseti Pharmaceutical Group, President of the UN Global Compact Network Hellas and member of the Board of SEV, was awarded an Honorary Doctorate by the Department of Pharmacy of the School of Health Sciences of the University of Athens IEKPA).

This is the top recognition of the university community in the person of Mrs. Ioulia Tseti, in terms of her many years of research work, but also her continuous and tireless actions towards society, the new generation and the environment.

The inauguration ceremony took place on Tuesday, June 14, 2022, in the Great Hall of the University of Athens, in the presence of the Rector’s Authorities, His Eminence the Metropolitan of Arta, professors and students, representatives of the business world, executives of the Tsetis Group and journalists. 

Afterwards, the honoree gave a speech entitled: “The anthropocentric character of pharmacy today and tomorrow

UNI-PHARMA was distinguished with the top business award of EVEA for Corporate Social Responsibility on Thursday, June 9, 2022, in the Peristyle of the Zappeion Megaron.

The award was received by the President and CEO of the Tseti pharmaceutical Group of Companies Mrs. Ioulia Tsetis, as well as the CFO of the Group Mrs. Irini Tsetis, by the Prime Minister Mr. Kyriakos Mitsotakis, in the presence of the President of EVEA (Athens Chamber of Commerce and Industry) Mr. Giannis Bratakos.

As Mrs. Iulia Tsetis emphasized in her short greeting,

 “Honorable Mr. Prime Minister,

Your presence here today confirms and seals the government’s commitment to supporting businesses with a human face. This also represents the award we receive today. It justifies all of us who work tirelessly in crises of all kinds, giving hope where it is lost. Because for us, for over half a century of life, our strong BELIEVE and plilosophy that we put into practice, is: “Value for Man, Responsibility for Society”.

OFET – with the pharmaceutical companies UNI-PHARMA and InterMed, the trading company in Cyprus Pharmabelle and the model medicinal plant extraction industry UniHerbo – is proud of its continuous actions aimed at strengthening society, research and the new generation and environmental protection.

“Violence and harassment at work is a very crucial issue. The adoption by companies of measures and policies to prevent and combat violence and harassment at work, in addition to being mandatory and necessary, not only to promote broader social goals, such as the elimination of discrimination, respect for diversity and safeguarding of the dignity of each individual, but also because it contributes to the smooth and more productive operation of each business “.

With this key message, and with the support of the SEV Guide to Business for Work Without Violence and Harassment, the Association for Diversity, Inclusion and Equality organized an open digital event on “Work Without Violence and Harassment: SEV Guide for Business “yesterday, (Monday, May 16, 2022). The event was addressed by, among others, Mrs. Maria Syregela, Deputy Minister of Labor and Social Affairs in charge of Demographic Policy and Family and the head of the Group for Diversity, Inclusion and Equality and member of the Board of SEV Mr. Ioulia Tsetis.

Five important Awards in the institution of EXCELLENT PHARMACEUTICAL MARKET 2022, were won by the pharmaceutical companies UNI-PHARMA & InterMed.

These awards, underline once again, the dominant role of UNI-PHARMA & InterMed products in pharmacies, the acceptance and trust of the citizens – consumers and the excellent cooperation for years with the community of pharmacists.

The Pharmaceutical Market Excellence Award 2022 took place on March 30 at a glamorous event, at ELEON LOFT, and the companies, organizations and teams that stood out, were awarded for their action, actions, presentation of innovations or best practices for the benefit of pharmacy, the prevention and operation of pharmacies.

At the beginning of the event, the chairman of the jury Mrs. Daniela Malo, president of EEFAM, addressed a greeting, announcing the beginning of the award ceremony.

Note that the products that stood out are ALGOFREN Eff. granules, URISEDON, THE SKIN PHARMACIST, while the dynamic Sales Team of InterMed, winning the GOLD award, proved for the umpteenth time, its dynamic role and the reliability with which it collaborates with Greek pharmacists.

The CEO of the Tsetis Pharmaceutical Group of companies, MSc Pharmacist, President of the UN Global Compact Net Work Hellas and a member of the Board of Directors of SEV Mrs. Ioulia Tsetis, presented her own position regarding the role of Life Sciences in the economic recovery and the post-pandemic era.

Mrs Tsetis, gave an one-on-one interview to the journalist Mrs. Maria Nikoltsiou and more specifically in the HEALTH section on the topic: “GREEK LIFE SCIENCE: RECOVERING THE ECONOMY”.

The message sent by Mrs. Tsetis, is that the Life Sciences are a lever for the development of the economy, on the basis of which there must be contraction and social cohesion. This development can be based on two pillars:

First, at EQUAL DIVERSITY & INCLUSION, to unite the business world

and

Second, the 10 UN Declared Principles and the 17 Sustainable Development Goals. In Greece, these Authorities are represented by the Hellenic Network UN GLOBAL COMPACT NET WORK HELLAS, which has been headed for one year by Mrs. Ioulia Tsetis.

The President and CEO of the pharmaceutical companies UNI-PHARMA & InterMed and President of the UN Global Compact Network Hellas Mrs. Julia Tsetis, met on Monday 28 February 2022 in her office, with the Representative of the UN High Commissioner for Refugees in Greece, Mrs. Maria Clara Martin, in order to discuss and activate actions for refugees.

In the aftermath of the dramatic events we are experiencing in recent days in Ukraine, action must be targeted, immediate and coordinated. The actions of UNI-PHARMA & InterMed with the relevant UN Services, such as the UNHCR, are immediate because when people are forcibly displaced from their homes and country due to conflict, the official institutions of social dialogue need to come together and assist with sustainable solutions for the benefit of the people.

The two ladies Maria Clara Martin and Julia Tseti, with their groups, exchanging views on the burning issues of the day on a pan-European scale, pledged to implement joint actions aimed at both helping the refugees and their smooth integration into society and the labor market. In this direction, the two sides are ready to cooperate with the competent Greek authorities, civil society organizations and the private sector.

UNI-PHARMA was awarded the SILVER Award and the title: “CENTURY BRANDS 2022”, in the context of the 22nd Marketing & Sales Conference on: GREEK ECONOMY “The future development challenges”.

The conference organized by the Business Review magazine.

The conference took place on March 18, 2022 and UNI-PHARMA was distinguished for its 59 years of uninterrupted presence in the Greek pharmaceutical market. The award was received by the president and CEO of the Tsetis Pharmaceutical Group of Companies, pharmacist MSc, president of the UN Global Compact Network Hellas and member of the Board of BSE Mrs. Ioulia Tseti.

The conference was attended by the President of EVEA Mr. Giannis Bratakos – who offered the Award to Mrs. Ioulia Tseti – and the Commander of the Recovery Fund Mr. Nikos Mantzoufas.

UNI-PHARMA won two very important awards at the Green Awards 2022 organized by the BOUSSIAS group under the auspices of the Association of Graduate Environmentalists of Greece.

The pharmaceutical industry has acquired:

• 1 GOLD Award in the category 3.1.5 Best Green Business Model, entitled “Environment and Energy Management in the OFET Group”

• 1 Platinum Award as Green Company of the year.

UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES SA in particular, it was among the three companies with the highest score in the entire section in which it won the Platinum Award.

The event GREEN AWARDS 2022  took place on Thursday, March 17, 2022, at the Radisson Blu Park Hotel, where for the 2nd consecutive year in Greece, products, services and development processes that promote the GREEN economy and Eco Living were awarded and promoted.

In total, 29 companies were distinguished from a wide range of business activity in all categories of awards.

A series of important distinctions, which rank the Tsetis Pharmaceutical Group of Companies at the top of the actions of the circular economy, sustainability and energy management, was recently awarded by OFET.

These are the awards in the events of the BOUSSIAS group, Circular Economy Awards 2022 and Energy Mastering Awards 2022.

The unique awards for the circular economy in Greece, the Circular Economy Awards 2022, announced the winners on Wednesday, February 23, 2022 at the Radisson Blu Park Hotel, in a live covid free Award Ceremony. The innovative practices that emerged through the Circular Economy Awards prove that, even in a year full of challenges, the transition to a circular economy, the new sustainable economic model for business and country development, continued unabated.

At the Circular Economy Awards 2022, UNI-PHARMA was named Circular Economy Company of the Year, a distinction that garnered the highest overall score of all the nominations companies.

Regarding the Energy Mastering Awards 2022, these are awards related to energy management and business sustainability.

With a total of 7 distinctions, UNI-PHARMA also won the title: Stewardship Award for Efficiency Initiative.

To the important 26th AEEDC Dental Exhibition in Dubai, from 1 to 3 February 2022, participated the Tsetis Pharmaceutical Group of Companies.

More than 3,000 exhibitors participated in the exhibition, with more than 4,000 brands, 155 countries, while it is estimated that 55,000 exhibitors visitied the 26th Dental Exhibition.

InterMed, with a rich portfolio of dental preparations and therapies for home and professional use, is considered to be the absolute protagonist and specialist in matters of oral health.

 

The 3rd Monday of January is the one that has been characterized as the most depressing day of the year, according to researchers from Great Britain and is called Blue Monday.

According to their explanation, this day is particularly stressful due to the heavy winter that prevails, the end of the festive atmosphere of Christmas and the expenses that took place in the previous period.

However, surely many of us have extra reasons that burden our psychology and mood for much more than a Monday of the year!

Lack of motivation, the daily routine that is difficult especially in the context of the prolonged pandemic, the stress in order to cope with the demands of the work, family and social environment are the most common and prevalent common suspects.

Solumag Saffron & curcumin, by InterMed

Fortunately we can find at pharmacies, the Solumag Saffron & curcumin by InterMed. It is the fastest, easiest, natural and delicious way to get in the mood!

Its composition is based on Saffron [Affron®], a clinically studied saffron extract [Crocus sativus L.) that has been shown to improve mood in just 4 weeks by significantly reducing depression, fatigue, confusion, anger and stress. (1)

One sachet of Solumag Saffron & curcumin a day in a little water, is enough to feel the mental well-being and relaxation you need.

Highly enriched with magnesium, high bioavailability (2) curcumin and B-complex vitamins that promote psychological function, enhance the reduction of fatigue and the normal functioning of the nervous system.

InterMed, pharmaceutical company of OFET (Tsetis Pharmaceutical Group of Companies), is pleased to announce that with its support – donation to the Non-Governmental Organization BE LIVE, a healthy baby girl was born on November 29, 2021,

The new born girl, is the first child in the family to undergo IVF method, and who lives in island of Kea (Tzia).

The in vitro monitoring and treatment was undertaken by the reproductive gynecologist Mr. Vassilis Kellaris, while the embryo transfer took place on April 14, 2021 at the Mitera maternity hospital.

Through the collaboration with the Organization and the BE LIVE Program – of doctors Kellaris and Chiniadis – which supports infertile couples making their dream of starting a family a reality, the Tsetis Pharmaceutical Group of Companies, expresses in the best possible way, the imprint of social of sensitivity and supply.

Also, InterMed, in the context of this collaboration, recently covered the nutritional supplements of 30 infertile couples, for the preparation of IVF cycles

The inaugural event of the UN Global Compact Network Hellas “Connecting the dots for Sustainable Development” was implemented with great success, on December 8, 2021.

The event, highlighted the cooperation of all parties as a necessary component for creating a sustainable and inclusive future in the country, liaising with representatives of Government, the United Nations, business, civil society, academia and local government. 

During her opening remarks, the President of the UN Global Compact Network Hellas, Ms. Ioulia Tseti, stated specifically that legitimate effects in all areas requires collective action. Starting with a common language that is the Ten Principles of the UN Global Compact, and at the same time contributing to the SDGs especially to those whose businesses can lead change such as the SDG 13 – Climate Action Goal “. Concluding the event, he stressed that “Creating a sustainable and inclusive world – which consciously leaves inequalities behind – is a collective affair and we all agree on that. It presupposes relationships of trust, it requires credibility, transparency and determination “.

“Run with your heart… for your heart!”

This was the main message of the CardioRun 2021 race, in which the pharmaceutical company Uni-Pharma, participated as a proud sponsor.

The fight was of a humanitarian nature and the proceeds will be used for the purchase of defibrillators in remote areas of Greece, with the care of the Hellenic Cardiological Society.

CardioRun was co-organized by the Hellenic Cardiological Society, the Association of Greek Olympians, the Panhellenic Association of Physical Education Graduates, the Panhellenic Association of Gyms and the Association of Gym Owners of Attica.

 

Another honorary award, which seals the social contribution but also the continuous support to health, the pharmaceutical industry and the business, was received by the president and CEO of the Tsetis Pharmaceutical Group of Companies, pharmacist MSc, member of the Board of SEV and president of UN Global Compact Network Hellas Mrs. Ioulia Tsetis.

The honorary award in the person of Mrs. Ioulia Tseti – which was received by Mr. Spyros Kintzios – concerned the overall contribution and support of the president and our Group, to society, health, but also to the development of the Greek Pharmaceutical Industry.

The organizers of the event were the TWO FORUM, organized by the 6th Forum for Nutrition-Health-Beauty, Business Development & Investment in Greece. This Forum started 7 years ago, aiming at reputable information, bringing scientists and businesses closer to society and man.

The event took place on October 23, 2021, at the Peristyle of the Zappeion Palace.

The largest charity race in the world, the 5th NO FINISH LINE, which strengthens the Union “TOGETHER FOR THE CHILD”- MAZI GIA TO PAIDI, was supported by the pharmaceutical companies Uni-pharma & InterMed.

The team of employes of Uni-pharma & InterMed, ran and walked in OAKA (the Olympic athletic stadium at Marousi Athens) – from Wednesday, September 29 to Sunday, October 3, 2021 – recording kilometers which were translated into money, which in turn were directed to children in great need of support and care. The pharmaceutical companies Uni-pharma & InterMed, with great joy and responsibility once again supported the NFL fight, sending the message of solidarity and social responsibility.

The participants and the support teams managed to reach 31,548.8 kilometers! All together for the Union “Together for the Child”!

The Tsetis Pharmaceutical Group of Companies (OFET) is proud of its continuous and tireless actions aimed at supporting vulnerable groups in society, science, the new generation and the Environment.

Uni-pharma & InterMed received five important awards – one GOLD, two SILVER and two BRONZE – for bioclimatic plant, technology utilization, innovative systems in production, crisis management and the Sustainable Development Strategy, at the event of Manufacturing Excellence Awards 2021.

The Greek companies of the industrial sector and the processing that stood out for their best and innovative practices and products, were awarded at the Manufacturing Excellence Awards 2021.

At the award ceremony of the third edition of the Manufacturing Excellence Awards of Boussias and the Manufacturing magazine held at Ktima Kallisti on the evening of Tuesday, October 5, 2021, more than 240 senior executives and CEOs of the awarded companies had the opportunity to meet again. representatives of ministries, organizations, agencies and industry associations.

Analytically, the Awards for both the pharmaceutical companies, are as follows:

GOLD, for crisis management of Tsetis Pharmaceutical Group of Companies,

SILVER for the new bioclimatic plant of Uni-pharma

SILVER for the new innovative systems in the production of Uni-pharma

BRONZE for the Strategy of Tsetis Pharmaceutical Group of Companies (OFET) ESG (Environment, Society, Governance)

BRONZE for the Sustainable Development Strategy of Tsetis Pharmaceutical Group o f Companies (OFET).

Three very important awards – for Ethical Business, the Green Sustainable Future and Environment and the top relaunch of the brand EVA INTIMA – were received by the pharmaceutical companies Uni-pharma & InterMed, during the BEST IN PHARMACY AWARDS 2021 awards.

In its 4th event, the BOUSSIAS Best in Pharmacy Awards highlighted the companies and pharmacy products that stood out for their good marketing practices and innovation.

The companies that received the highest scores in the overall evaluation and were distinguished, were awarded at the Awards Ceremony held at Kellari Papachristou, on Wednesday, September 29, 2021. The evening was a great celebration for the pharmaceutical industry and after a year and a half of  the pandemic Covid, with special conditions and restrictions, about 150 executives were given the opportunity to meet and be rewarded for their successes.

Analytically, the Awards for both the pharmaceutical companies, are as follows: 

GOLD AWARD for Uni-pharma as Top Green Company

GOLD/ PLATINUM AWARD for Uni-pharma as Top Responsibe Company

GOLD AWARD for InterMed for the Top relaunch of the brand EVA INTIMA. 

The donation of a new modern and technologically perfect amphitheater of 100 seats, with a budget of 120,000 euros, for the Athens School of Pharmacy of EKPA, was carried out by the AMKE KLEON TSETIS Foundation, of the Tsetis Pharmaceutical Group of Companies.

The Head of the Foundation, MSc Pharmacist, CEO of the Tsetis Pharmaceutical Group of Companies, President of Global Compact Network Hellas, and Member of the BoD of SEV Mrs. Ioulia Tseti, inaugurated the Hall on Monday afternoon, September 27, 2021, in the presence of the President Of Health Sciences of EKPA Leandros Skaltsounis, of the Rector of EKPA Professor Athanasios Meletis Dimopoulos, of the Vice Rectors Nikolaos Voulgaris and Athanasios Tsakris, of the Dean of the School of Health Sciences Manolis Pikoulis and from EPPA pres.

Professor of Forensic Medicine and Toxicology Chara Spiliopoulou spoke about the contribution of the AMKE KLEON TSETIS Foundation to the research and educational activities of the university community.

The donation of the amphitheater – which has all the possibilities of online and interactive education of students – was made in the context of the celebration of the 200th anniversary of the GREEK REVOLUTION.

The new amphitheater of the School of Pharmacy of EKPA, is named “Kleon Tsetis Foundation”, the creator of the pharmaceutical industries Uni-pharma & InterMed, who was a restless research spirit, creative pharmacist, intelligent industrialist. He inspired with his work, his example, his remarkable social contribution and his ethos, a whole generation of pharmacists and academics, while his valuable lessons are followed also to nowadays by the 568 and more employees of the Tsetis Pharmaceutical Group od Companies. .

The Green Team of the Tsetis Pharmaceutical Group of Companies (OFET) visited the emblematic island of Delos- the island of the Goddess Artemis and the God Apollo, and the Museum of World Cultural Heritage, on the weekend of September 4 and 5 2021. 

The target of the visit, was an interesting environmental action. Specifically, the Green Team of the pharmaceutical companies Uni-pharma and InterMed, in collaboration with the Environmental Organization All For Blue, carried out underwater and coastal cleaning on the island of Delos.

It is worth noting that from the cleanups, more than a ton of garbage was collected, while the divers who participated in the action, were all athletes of the Free Diving of our National Team. The divers were accompanied by a submarine drone, which recorded step by step the entire cleaning action.

This important environmental action under the title #KeepDelosBlue is part of the OFET Corporate Responsibility Program, a strategy, which for years includes actions for the protection of the environment and ecosystem, support of vulnerable groups of society, support and empowerment of the new generation and scientists. 

Mrs Ioulia Tsetis, CEO of OFET, pharmacist MSc, president of the Global Compact Network Hellas and member of BoD of SEV, was present at this interesting and fruitful action.

 

The Cypriot market also rewards the products of the leading pharmaceutical company InterMed.

In particular, the sunscreens LUXURIOYS SUN CARE INVISIBLE SPRAYS, signed by InterMed, and InterTech technology, were awarded a Silver Award, in the context of the CYPRUS BEST IN PHARMACY 2021 event at the Artos Foundation in Nicosia, on June 29, 2021.

At the same event, the industries Uni-pharma and InterMed, were distinguished with a GOLD Award, in the category, TOP RESPONSIBLE BUSINESS! The Cyprus Best in Pharmacy Awards 2021 presented the most successful pharmacy products, distinguished for their innovation, successful marketing and the most commendable offer to society and the environment. With more than half a century of life, the Tsetis Pharmaceutical Group of Companies (OFET), is a stable reference point, not only for the pharmaceutical market, but also a reference point for society.

The industries of Tsetis Pharmaceutical Group of Companies, Uni-pharma & InterMed, received four important distinctions, in the event “LEADERS OF THE GREEK ECONOMY 2021“, which organized for the 6th time by the Direction Business Network, on July 19th.

The companies that stood out for their financial performance in the decade from 2010 to 2020 were honored at the Awards Ceremony-institution for Greek business.

The awards were based on the official financial data of the companies as reflected in their financial reports and are presented in detail in the publication “The Strong of the Greek Economy” of the Direction Business Network, which has just been released and is also dedicated to the decade 2010-2020.

Also awarded were the Greek Business Champions of the Decade, companies that managed to simultaneously increase their turnover and profits before taxes by more than 50% comparing the financial year 2010 with that of 2019. These include Uni-pharma & InterMed , while among the four distinctions received by OFET, is the “Solidarity Excellence Award“. With this award, companies were honored for their commitment to the value of human life and their solidarity with society in practice with the advent of the Covid-19 pandemic.

The awards were received by the President and CEO of OFET Mrs. Ioulia Tseti, the Head of HR and CSR of OFET Mrs. Smaragdi Talaki and the Corporate Development Manager of Uni-pharma Mr. Spyros Kintzios.

Two very important awards, which reflect the design inspiration, the innovation, the enthusiasm, but also the sustainability that underlines the value of the branding, was received by the pharmaceutical company InterMed, at the PACKAGING AWARDS 2021 on Monday 12 July, at House 124 in Athens .

This is the new dermatological series Skin Pharmacist, which was distinguished with a GOLD award – Graphic Design Innovation as Minimal recyclable packaging and the long-established line of women’s care Eva Intima, which this year was released in a new packaging and was distinguished with a SILVER award – Graphic Design Innovation, as a Doric, recyclable package.

The awards were received by Mrs. Sappho Hatzikyriakaki – Head of Creative Department of Tsetis Pharmaceutical Group of Companies, and Myrto Rapti – brand manager of InterMed.

Tsetis Pharmaceutical Group of Companies, awarded this year again, as a Diamond of the Greek Economy 2021.

The event, took place on July 7, 2021, at the GALAZIO estate, in Elliniko, Attica, and organised by the New Times Publishing Group – headed by Mr. Spyros Ktenas.

The Tsetis Pharmaceutical Group of Companies, was distinguished for its continuous investments in a difficult and demanding environment, for the significant increase of its financial results and its targeted strategy in terms of Corporate Responsibility , (CSR) which includes actions for society, the environment, science, research and the new generation.

The award was received by the Head of Exports of OFET Mr. George Spigos, who praised the work of all companies that stood out, which as he stressed toil, produce and invest in a difficult and demanding time, due to the pandemic, with the employees however, giving their best.

“The Tseti Pharmaceutical Group is moving dynamically with the precious legacy of Kleonas Tseti, who envisioned a modern pharmaceutical industry, which will meet the needs of patients with high value-added products,” he said in his statement Mr. Spigos, adding that “the DIAMONDS 2021 award is a recognition of our efforts and a responsibility for the future.”

With the emblematic slogan – “We invest in us, we build the future” # ElladaAllios-this year’s General Assembly of the Association of Greek Industrialists (SEV), “embraced” the world of work with different characteristics and placed at the top of the Public Dialogue and equality, creating a new Working Group.

This year, the Association of Industries and Businesses (SEV) will systematically focus on highlighting these three elements, given that they are fundamental to business development.

The above was mentioned by Mrs. Ioulia Tsetis, MSc pharmacist, CEO of Tsetis Pharmaceutical Group of Companies (OFET), member of the Board of SEV & President of Global Gompact Network Hellas, in her speech at the General Assembly of the Association.

The restoration of ecosystems is the beginning of the important mission of the United Nations for the next decade.

Only with healthy ecosystems can we improve people’s living standards, compensate for climate change and stop the collapse of biodiversity.

On the occasion of World Environment Day – it  is celebrated every year on June 5 – it is important to listen for a while, how much we have hurt the environment and the ecosystem and finally, how much we systematically destroy biodiversity. This year, World Environment Day focuses on the issue of ecosystem restoration with the triptych “Reimagine. Recreate. Restore. ”, Launching the United Nations action,“ UN Decade on Ecosystem Restoration ”for the period 2021-2030, which aims at cooperation of all parties to prevent and stop the destruction of the environment, as well as the revival of ecosystems in the next ten years are crucial.

The Tsetis Pharmceutical Group of Companies gives great importance to the protection of the environment, with a series of actions of strategic importance.

Indicative responsible actions, include the big action SAVE THE SEA for cleaning the seas from plastics.

At OFET Group, with the integration of green practices, we take care of the safe management of expired or damaged pharmaceutical preparations and the recycling of packaging materials, in the context of sustainable development.

In particular, we implement the pioneering and innovative environmental program “sorting at source” to achieve the goal of 100% recycling of solid non-hazardous waste by species with color separation of special recycling bins and “zero waste” technology. Our new environmental goals for the five years 2021-2025 are the development of products with packages of improved sustainability performance.

We aim at the proper management of water resources, the use of sustainable raw materials and the development of products with packages of improved viability, with the possibility of recycling, use of alternative materials, saving volume or weight of packaging materials, etc.

OFET Group has advanced its Strategic Social Responsibility on environmental issues: Extending environmentally friendly solutions to the design of pharmaceutical products. The adoption by the Group of the use of new reusable antiseptic packaging – is the most recent achievement of the Group in the fight for a greener and cleaner planet.

Four significant Awards, which further strengthen the image of the companies of the Tsetis Pharmaceutical Group of Companies in the consumer consciousness, received products of Uni-pharma and InterMed, respectively, in the competition “Pharmacist Choice 2021: The big winners of Pharmacy products” organized by the Boussias group, on Tuesday, May 25, 2021.

In a year that was particularly demanding for the whole pharmacy industry, leading companies and distinguished scientists met the requirements of this new institution, contributing significantly to its success. The Special Committee, as well as members of the pharmaceutical community across the country, evaluated the products through a special electronic platform, but also through the nationwide research conducted by Global Link.

These 4 Awards further value the products that were awarded, as well as the companies in the consciousness of the patient and the consumer, as they were voted by pharmacists and are a reliable choice by the specific health professionals.

In detail, the distinctions received by the products of Uni-pharma InterMed are as follows:

– Category Vitamins: Winner distinction in B12 FIX: The only dispersible preparation in its category, product of Uni-Pharma l Kleon Tsetis SA

– Category Vitamins: Runner-up distinction in D3 FIX: A preparation with the signature of reliability of Uni-pharma

– Category Welfare Products: Winner distinction in LACTOLEVURE – The number 1 probiotic product in Greece

– Category Sensitive area: Winner distinction in EVA INTIMA, product of InterMed Ioulia & Irini Tseti Pharmaceutical Laboratories SA. This is a complete series of women’s care, which now appears with a minimal & clean cut appearance, but with the same quality and reliability.

 

Two Gold and one Silver award were won by the Tsetis Pharmaceutical Group of Companies on Thursday, May 20, in the context of the Health & Safety Awards 2021, organized for the 8th year by Boussias under the auspices of ELINYAE.

In the most challenging year – during which the pandemic repeatedly shook economies, societies and health systems – the industries of the Tsetis Pharmaceutical Group – Uni-pharma and InterMed – managed to stand out, once again putting the security, prevention, as well as an organized and coordinated strategy, not only for their employees but also for all their partners and suppliers.

In detail, the awards received by OFET are as follows:

In the category “Healthy & Safe Workplace”, GOLD award in the New bioclimatic building of UNI-PHARMA – Healthy & Safe Workplace

In the category “Facility Upgrade & Modernization / Work Health and Safety Invention” GOLD award, in the New innovative mechanical equipment in the production of medicines of Uni-pharma.

In the category “Crisis Response”, SILVER award to the Tsetis Pharmaceutical Group, for crisis management. –

Her own proposal for the next day of the pandemic COVI-19, which is linked to maintaining as many jobs as possible, but also to creating a new production model based on the autonomy of raw material production, adequate research funding and sustainable development , underlined the CEO of the Tsetis Pharmaceutical Group of Companies, member of the Board of SEV and President of the Global Compact Network Hellas, Mrs. Ioulia Tseti, at the 6th Delphi Economic Forum, which takes place from 10 to 15 May at Zappeion Megaron.

Ms. Tseti participated in a panel with other representatives of the pharmaceutical industry entitled “Health Systems of tomorrow: Pharma Policies for Growth” and had the opportunity to speak in english, both as head of a large Greek Group – consisting of the industries Uni-pharma and InterMed, the trading company in Cyprus Pharmabelle and the medicinal plant extraction industry UniHerbo- as well as with its dual institutional capacity, the member of BSE and the president of GCNH.

The statement

Every time we experience a serious crisis, of any form, we need to have the ability to transform the problem, to be able to learn from it and to move forward stronger than before.

We have learned a lot from the pandemic. It shook us and taught us to act with wisdom, responsibility, and solidarity. This serious health crisis has affected the economy, society, the labour market and of course on all our social behaviours.

It is a time for cooperation, solidarity and social cohesion/unity. The post-pandemic day requires Leaders with empathy and sensitivity, with knowledge, sobriety, and rational thinking. Leaders with a vision that inspires and transforms goals and numbers into action and prosperity.

The main goal/objective/focus of the new era and the restart of the global economy must be the preservation of jobs – millions of which have been lost in the last year – and the shift to a new productive model. A model pivoting on industrial production, sustainable development, and environmental protection.

One of the dominant issues that emerged during this crisis, is the autonomy of production, raw materials and finished products of food and medicine.

Self- sufficiency of production, adequate funding of research in producing new drugs, the cooperation among research groups, connection of production with innovation, all this should constitute the new foundations on which the pharmaceutical industry in Europe should be based. All this within a framework of new technologies, telemedicine and digital reform, where our country has proved that it has strong reflexes and capabilities. It is our duty to give space and opportunities again to domestic production, so that it can flourish. In previous years, the deindustrialisation of Europe and Greece cost us dearly in terms of jobs and growth.

Along with the Digital Revolution, a second astonishing Revolution is already on the way: that of Biotechnology. If solidarity and collaboration among researchers around the world had been greater, we would have seen more spectacular results in relation to innovative therapies, and we would have we would have gone back to normal faster.

This Biotechnology Revolution, with the participation of researchers from around the globe will very soon create innovative therapies that will contribute to the treatment of future epidemics and chronic diseases. Challenges should not frighten us. On the contrary, they should make us stronger. The future belongs to those with imagination to shape it!

The follow-up question according to Mrs Merkel’s statement

 Mrs Tseti you talked about the self-sufficiency of production. On April 24th at a conference of EU conservative parties Chancellor Merkel criticized the European strategy towards the pharmaceutical industry saying, and I quote, “for many years, we have not treated our pharmaceutical industry in Europe so very well. We have had outflows to America. And the United States of America has probably the strongest pharmaceutical industry, at least in the Western world”. Even though she acknowledged the importance of the European facilities in countries such as Belgium, Holland, Germany, France, Spain, her statement seems to hint at the need for a different way forward for the pharmaceutical industry in the EU. Could you comment on that and what do you think the “next day” in European pharma should look like? Where should the focus be?

Mrs Agouridis, the reason for our self-criticism is Mrs Merkel’s statement.

Why has the European Union failed to support a dynamic and life saving industry, such as the pharmaceutical industry?

The de-industrial-isation of Europe in the ‘70s, did not take place overnight, it took place gradually, due to high costs of raw material, high wages, but also due to the demands of the trade unions, as well as for environmental reasons. Manufacturing plants were transferred outside Europe, along with technology and know-how. Today with this pandemic the consequences are obvious. We suffer from deficits and raw material shortage.

It is self-evident that when basic production of food and medicine is affected, citizens and society are directly affected, as well.

In my opinion, we can gain time by investing in innovation and research and by supporting the enhancement of production in Europe. Of course we should do this while taking environmental and sustainability issues very seriously. In order to strengthen a robust industry in Europe we should rationalise taxes and relate them to innovation and growth.

We should reinvent the value of working in production. We should re-approach the working force and make working in industrial production attractive again. We should reward industrial profit and the people who work there.

We need to make sure that mistakes such as the one with BioTech will not be repeated. BioTech researchers received European money to develop their product, and then they ended up selling their innovation to the States.

The pandemic – as painful as it is – has given us an opportunity to wake up and realize that in the future we need to be more cooperative, to act with solidarity and turn to the BIG PHARMA model, making the most of technology, telemedicine, and the potential that digital revolution gives us.

In Europe it is fundamental that everybody has the same right to health and education. Social health insurance for all is a core value in Europe. With this pandemic, we can now see what this means. In order for someone to be safe, no matter how much money he or she has, everybody needs to be safe.

As a member of Foard of Directors of SEV, I would like to tell you that there is an insuperable need to strengthen the Greek production, to make Greece a hub of Innovation and Excellence and to “embrace” digital platforms more vigorously. After all, the favorable financial environment of the Recovery Fund (RF), gives us this opportunity, and we must use it wisely.

As President of the Global Compact Network Hellas, I firmly believe that all the above make sense only if we embrace the 10 principles and 17 sustainable goals of the UN.

The challenges will never stop, we may be experiencing the challenge of Covid 19 today, but it is certain that other crises await us in the future. Only with social cohesion and solidarity, will we be able to deal with these future challenges!

Ioulia Tseti in “IGETIDES” of KATHIMERINI: Ability is a matter of temperament & not gender.

The above phrase, underlines Mrs Ioulia Tsetis, pharmacist MSc, CEO of Tsetis Pharmaceutical Group of Companies and President of A’ BoD of Global Compact Network Hellas.

In an excellent tribute to the special edition I KATHIMERINI – KATHIMERINI “Igetides”, the CEO of the Tsetis Pharmaceutical Group of Companies, said in an interview, that it is our obligation and main priority is, that every job, is filled by people who meet all the necessary criteria. they work with passion. “. Among other things, she stated that “Our goal is to create such an environment, which ensures harmonious integration and inspires each of us, so that everyone of the 600 employees of OFET, gives the best of his potential.”

With an Honorary Award “ARISTINDIN” in memory of Kleonas Tsetis and six more awards (two Platinum, one Gold and three Silver), the pharmaceutical companies Uni-pharma & InterMed, shone at the event Pharmacy Market Excellence 2021 – Aristeia Farmakeytikis Agoras 2021. The event took place on March 10 digitally. 

The first special award “Aristindin” was awarded, after death, to a leading business figure of our country, Kleonas Tsetis, founder of the pharmaceutical industry Unipharma and InterMed. An emblematic figure not only of the pharmaceutical industry, but also of research and business in general. The award was received by Mrs. Ioulia Tseti, President and CEO of the Tseti Pharmaceutical Group (OFET).

The categories of the awards that were distinguished by Uni-pharma & InterMed are as follows:

Corporate social responsibility in the pharmaceutical market during the pandemic • Silver: UNI-PHARMA

Best advertising in the media for pharmacy products • Platinum: UNI-PHARMA. The award was received by Mr. Anastasios Bithas, Digital Media Manager.

Training – information for pharmacists: Training programs • Silver: UNI-PHARMA

Launch of a new pharmacy product • Silver: UNI-PHARMA for TONOSAN

Pharmacy product design and packaging • Platinum: INTERMED for the EVA Intima. The award was received by Mrs. Myrto Rapti, Brand Manager InterMed

Distinguished sales team in pharmacies • Gold: INTERMED. The award was received by Mr. Antonis Zeppos, Commercial Director INTERMED.

An important distinction was won by the President and CEO of the Tsetis Pharmaceutical Group ofCompanies, Mrs. Ioulia Tseti, as she was elected President of the first Board of Directors of the Global Compact Network Hellas.

GCNH, is the Local Network of the UN Global Compact. Following the successful holding on January 20, 2021 of the General Assembly and the nominations for the election of members of the first Board of Directors of the Global Compact Network Hellas, which is the Local Network of the UN Global Compact, the nine (9 ) members who were elected for a three-year term, proceeded on Monday, February 22, 2021, to form a body with the following composition:

Chairman: Ioulia Tseti (UNI-PHARMA PHARMACEUTICAL LABORATORIES S.A. & INTERMED S.A.)

Vice President: Haris Plakantonaki (STAR ​​BULK CARRIERS CORP.)

Secretary: Sofia Daskalaki-Mytilineou (MYTILINEOS SA)

Treasurer: Maria Alexiou (CSR HELLAS)

Members: Chiara Konti (EY GREECE) Konstantinos Konstantinou (SEV- ASSOCIATION OF BUSINESS AND INDUSTRY) Konstantinos Macheiras (LAND ORGANIZATION) Pakis Papadimitriou (ATHENS INTERNATIONAL AIRPORT) Athanasios Polychronopoulos (POLYECO SA). 

The United Nations Global Compact (UN Global Compact) is a global voluntary initiative, based on the commitment of businesses to implement universal sustainability principles and take action in support of the 10 United Nations goals.

With the title “EXPORT LEADERS”, and in fact in a difficult year due to the pandemic, the industries of OFET (Tsetis Pharmaceutical Group of Companies) UNI-PHARMA & INTERMED were distinguished, during the digital forum “Greece of Extroversion – Export Leaders 2021”, organized by the publishing group NEW TIMES on February 2, 2021.

The digital event sent a strong message of optimism for the restart of the Greek economy, which was conveyed by the participants with significant interventions and strong participation of business executives. On behalf of the Tsetis Pharmaceutical Group of Companies, the head of exports Mr. George Spigos participated, who referred to the strong extroversion of industries in over 66 countries with the brand names by Uni-pharma & InterMed, but also to the fact that the industries, play a key role in the world business map!

With another award, which emphasizes its constant focus and emphasis on ETHICAL BUSINESS and responsible entrepreneurship, the Tseti Pharmaceutical Group of Companies (with the Uni-Pharma & InterMed industries) was awarded at December 16, 2020.  

This is the RHETORIC OLYMPIC WREATH award, with which OFET was distinguished, during the 13th Awards Ceremony “RESPONSIBLE MANAGEMENT EXCELLENCE AWARDS BY EBEN”.

As Mr. Mr. George Costopoulos, the head of OFET HR,  mentioned, «Ethical Business and Social Responsibility are a way of life and a philosophy of our Group. Our values ​​under the acronym TELEIA, which signify Teamwork, Ethos – Ethics, Continuing Learning, Excellence, Innovation and Responsibility – Accountability, is the main canvas on in which the Group’s industries weave their entire Strategy.

The pandemic – COVID-19, as an accelerator for the economy, health & society – Do not be afraid – We come out wiser.

This article by Ioulia Tseti- pharmacist, president and CEO of the Tsetsi Pharmaceutical Group of Companies, member of the Board of SEV,- was publised in newspaper KATHIMERINI – EPIXEIREIN, special edition, January 10, 2021.

 

Tsetis Pharmaceutical Group of Companies (with Uni-pharma, InterMed, Pharmabelle & UniHerbo) belongs from December 7, 2020, to the leading group of “The Most Sustainable Companies in Greece 2020”,  that means, the companies with the greatest sustainable growth.

These 25 Greek companies – models, which highlight the Business Charter of Sustainable Development in our country. This is a technical evaluation and not an award, which was carried out by the executives of the Quality Net Foundation Network and lasted several months. As a matter of fact, this makes the title “Most Sustainable Companies” for the industries of OFET, especially important.

These companies that are part of the leading team of the elites of the Greek business scene, stood out based on their technical evaluation, from the «Sustainability Performance Directory».

They operates as examples of good business and ethical practice and can play an important role in shaping a new development model that is directly linked to the competitiveness of Greek companies and attracting investment.

The 4th Digital Science on the Go, the Mobile Science Laboratory, organized by Uni-pharma & InterMed, pharmaceutical companies of the Tsetis Pharmaceutical Group of Companies (OFET), took place with great success on Friday, December 11, 2020.

The research team of Uni-pharma & InterMed, presented online and step by step, according to all safety protocols, due to Pandemic Covid, the creation of an WHO antiseptic and a vitamin supplement. Both companies, have huge and long lasting experience, according to these two formulations.The specific action that supports the research, the science and the new generation, is part of the Strategy for Corporate Social Responsibilito of Tsetis Pharmaceutical Group of Companies.

The online research laboratory was attended by professors and students of the Schools of Pharmacy as well as journalists.

With four awards (two Gold and two Silver) the industries of Tsetis Pharmaceutical Group of Companies (OFET) Uni-pharma & InterMed, were awarded among the leading industries in Greece by the Manufacturing Excellence Awards 2020, on December 2, 2020.

The 2nd organization of the Manufacturing Excellence Awards highlighted the most remarkable and innovative initiatives of the Greek industry, in the middle of a very crucial year, due the covid-19 pandemic.

OFET- Tsetis pharmaceutical Group of Companies, were distinguished for the new innovative production systems in the UNI-PHARMA flagship, the pandemic response with the new Emergency Plans for suspected case management and precautionary instructions from the corona, as well as the Business Continuity Plan for production, innovative equipment, productivity and efficiency.

On the occasion of the second strong wave of the Pandemic COVID-19 in Greece, the management of the Tsetis Pharmaceutical  Group of Companies,  proceeded, in another significant donation.

This time the recipient of the donation is the Mobile Health Groups (KOMY) of EODY, the National Organization of Public Health.

The management of the Tsetis Pharmaceutical Group of Companies, headed by the president and CEO Mrs. Ioulia Tseti, (the Group owns the industries Uni-pharma and InterMed, the commercial company in Cyprus Pharmabelle and the newly established pharmaceutical plant extraction company UniHerbo) decided to donate antriseptics and disinfectants to the EODY.

This donation specifically concerns 180 pieces of 500 ml Reval antiseptics and 150 pieces of Reval 150 ml BOV (spray) disinfectants, which will be able to support the important public health work performed by the Mobile Health Groups of EODY (National Organization of Public Health.

It is worth to note, that this is the 4th donation implemented by the Tsetis Group throughout the pandemic COVID-19.

Another significant Award, conquered OFET, Tsetis Pharmaceutical Group of Companies.

In particular, OFET with the industries Uni-pharma & InterMed, with over half a century of life in the pharmaceutical market, was distinguished on Tuesday, October 27, 2020, at the event SALUS AWARDS 2020 & KIND HEARTS, organized by NEW TIMES PUBLISHING on the Lycabettus Horizons.

The Group was awarded for its large donations to the Greek and Cypriot healthcare system during the first wave of the pandemic COVID19. Let us recall that the OFET administration, with decisive actions, supported the Greek and Cypriot health system, through three Large donations: 24 million doses and 60,000 doses of Unikinon (chloroquine) in Greece and Cyprus respectively and over 14,000 liters of antiseptics for the needs of the ESY (the Greek health Care system) The Group also distinguished itself for the investments of 20 million euros concerning the first historic factory of Uni-pharma, but also for the financial figures of the group, which recorded an impressive increase, more than doubling the net profits before taxes.

Vice President of the Board of Directors of the Group Mr. Thanasis Archontikis, received the Award SALUS AWARDS 2020 & KIND HEARTS!

The buildings of Uni-pharma & InterMed, pharmacompanies of Tsetis Pharmaceutical Group of Companies (OFET) n Kifissia, are liluminated pink, during October, in order to send a strong message against breast cancer.

October is the month that underlines the value of breast cancer prevention, awareness and information internationally. Uni-pharma and InterMed, supports the value of prevention and information and illuminates all its buildings in pink during the whole month of October.

Breast cancer is the most common cancer for women in Europe. About 1 in 8 to 10 women will develop the disease. It is estimated that every year in Greece, about 4,500 new cases are identified and of these about 1,500 lose their lives. Uni-pharma and InterMed management and employees, say YES to breast cancer prevention.

T4 is one of the Eternal Brands of Greece. 

As one of the ETERNAL BRANDS of our country, the T4 formulation of the pharmaceutical industry Uni-pharma was awarded, by a Bronze medal, on Friday, October 23, 2020.

T4 (levothyroxine sodium tablets) is a specialized therapy, aimed at treating thyroid diseases.

The T4 was licensed on July 29, 1981 and production began almost immediately. Today, it is available in 13 individual dosage contents.
It has been approved in 11 countries in the European Union and 7 other countries worldwide from Latin America to Asia and Africa. In detail, the countries in which it has been approved are the following:
Albania, Azerbaijan, Chile, Georgia, Macau, Nepal, Tunisia, Cyprus, Denmark, Finland, France, Iceland, Malta, Netherlands, Poland, Portugal, Spain, Sweden.

The Vice President of the Board of the Tsetis Pharmaceutical Group of Companies Mr. Athanasios Archontikis, received the significant Award, by the Deputy Minister of Development and Investment Mr. Nikos Papathanasis,.

Two significant Awards, were received by the industries of the Tsetis Pharmaceutical Group of Companies Uni-pharma & InterMed, during the 4th organization of the Facilities Management Awards of Boussias Communications, on Wednesday, October 21, 2020.

The two industries stood out and were awarded the Gold & Bronze Award for their innovation in facility management.

In an constantly changing and demanding environment, OFET (Tsetis Pharmaceutical Group of Companies) adapts its data around the maintenance of its facilities and the automation needs of its buildings, with an emphasis on digital innovation. 

The good practices and initiatives for the protection of the Environment, emerged dynamically, at the awarding of the Environmental Awards 2020, on the night of Thursday, October 15, 2020 at House 124 in Chalandri.

Tsetis Pharmaceutical Group o Companies (with  Uni-pharma & InterMed), won 4 important awards (two Gold and two Silver) in the fields related to its Environmental Policy, the new Bioclimatic Plant of Uni-pharma, the management of hazardous waste, the reduction of water consumption and the smart solutions energy.

World Handwashing Day today, October 15, and undoubtedly, this year’s celebration is even more important, due to the Pandemic – COVID-19.

Proper hand hygiene, is of great importance in nowadays, due to the serious health crisis of Pandemic. Proper hand Hygiene, also works preventively, against germs and diseases, while keeping away the unpredictable SARS CoV-2.

InterMed has in its portfolio a series of powerful formulations, with the use of which, you can be sure that you touch the ultimate hygiene of your hands: Reval Deep Cleansing hand wash and Reval Hand Gel. For every hour and every moment, wherever you are!

World Vision Day is the second Thursday of October (8th of October).

We take care of our eyes and visit our ophthalmologist when we face any problem.

InterMed has in its portfolio a series of preparations with the brand name Optofresh & Optonic (eye drops for relief and hydration, drops for allergic conjunctivitis, cleansing foam, masks for tired eyes, eye wipes and special nutritional supplements). special innovative formulas, soothe, moisturize and care for our precious eyes.

You will find them in pharmacies.

With a sense of solidarity, responsibility and social sensitivity, Uni-pharma & InterMed, companies of OFET (Tsetis Pharmaceutical Croup of Companies), supported once more, the GREECE RACE FOR THE CURE 2020 Competition organized by ALMA ZOIS.

This year, the Greece Race for the Cure®, adapting to the conditions imposed by the severe health crisis of the SARS-COVID 19 pandemic, went digital, but without losing its essence and kind character.women

The running team of OFET, ran and walked, with the vision to support the brave women with the breast cancer.

 #RFTC2020 #almazois #digitalRacefortheCure2020

@almazois

 

Best in Pharmacy Awards 2020: 7 significant Awards for Uni-pharma & InterMed & Pharmacy Company of the Year!

Gold, Silver, Platinum awards, including the top award “Pharmacy Company of the Year”, was won by the Tsetis Pharmaceutical Group of Companies with the industries Uni-pharma & InterMed, on the evening of Wednesday 16 September 2020, at the Best event in Pharmacy Awards 2020.

In particular, Uni-pharma and InterMed received the following awards:
– Two Gold, as the leading company responsible for the large donations of Unikinon (chloroquine) and antiseptics, during the pandemic SARS COVID-19,
– Silver as a leading Green company for the strong environmental footprint of Uni-pharma and for its “green” philosophy,
– Silver for the top launch of the TONOSAN nutritional supplement line.

Moreover, the two industries and OFET as a whole, won two Platinum distinctions. Specifically, in the category “Supporting our healthcare system – The great donations of Uni-pharma & InterMed during Pamdemic COVID-19”. 

September is a month dedicated to the fight against childhood and adolescent cancer by decision of the European Parliament.

According to official data from the World Health Organization (WHO), cancer is the leading cause of death for children, with 300,000 new cases being diagnosed each year in children and adolescents aged 0-19. In our country it is estimated that every year about 300 children are affected by cancer.

InterMed, company of Tsetis Pharmaceutical Group of Companies, supported once more Spetsathlon 2020 a very big sports meeting.

InterMed supported the sports meeting with the hand gel Reval.

Spetsathlon 2020, especially this year, due to Panedemic Covid-19, took place in Loutraki on September 5, 2020.

With two SilverAwards, Uni-pharma and InterMed, companies of Tsetis Pharmaceutical Group of Companies, awarded on Tuesday, July 21, 2020 at the Patient Partnerships Awards 2020 event.

The event was held for the first year by Boussias Communications and Health Daily under the auspices of the Hellenic Association of Pharmaceutical Companies (SFEE), the Panhellenic Association of Pharmaceutical Industry (PEF) and the Association of Specialists & Specialties (SAFEE).

The Tsetis Pharmaceutical Group of Companies, received a SILVER Award – Most Valuable Covid19 Pandemic Patient Support Program – for its contribution and support to the Greek & Cypriot health system during the pandemic Covid-19, and especially for the  donations of chloroquine (Unikinon) & antiseptics.

InterMed also received a SILVER Award, as the specialist in oral health – Mouth Hygiene Campaign Award.

Another significant Award for Tsetis Pharmaceutical Group of Companies.

Tsetis Pharmaceutical Group of Companies, with the industries of Uni-pharma & InterMed, awarded once more, as one of the Diamonds of the Greek Economy, at the DIAMONDS of the Greek Economy 2020 Business Excellence event, which took place on the evening of Wednesday, July 15, 2020 at the HILTON hotel Athens.

The important award was received by the President and CEO of the Group and member of the Board of SEV Mrs. Ioulia Tseti from the Minister of Development and Investment Mr. Adonis Georgiadis.

It is worth noting that the Minister Mr. Adonis Georgiadis thanked many times Mrs. Tseti on behalf of the Greek State, for her strong reflexes and initiative, to donate chloroquine and antiseptics to the Greek National Health System, during the most serious moment of the public health crisis, the Pandemic – Covid-19. As well, the group’s financial figures, recorded an impressive increase, reaching up to + 155% in net profit before taxes. Additionally, the Group invested 20 million euros, for the historic plant of Uni-pharma. 

Two important actions for the protection of the Environment and the marine ecosystem, were carried out by the Green Team of the Tsetis Pharmaceutical Group (with the pharmaceutical companies UNI-PHARMA & INTERMED) on Saturday, July 11, 2020, in Syros island and Marathon Attiki.

In particular, Saturday, July 11, from 10.00 to 13.00 o’clock, the Green Team of Tsetis Pharmaceutical Group carried out underwater and coastal beach cleaning activities on the beaches of Syros, in collaboration with the Head of the Hellenic Environmental Organization “All for Blue” Mrs. Katerina Topouzoglou and her specialized diving Team.

The goal of the Green Team was to clean the seas and shores of Agathopes and Fetouri of Syros, under the logo “Save the Sea”, in order to reduce the environmental footprint.

The said cleaning activities were carried out with the presence of Syros Port Authority, Syros Health Center and the Department of Environment and Cleanliness of the Municipality of Syros, as well as the CEO of Testis Pharmaceutical Group, Mrs. Ioulia Tseti.

Moreover, the “Save the Sea” activities were implemented with the zero waste method, with the All For Blue protocol, which has only reusable equipment avoiding disposable plastics.

The waste will be weighed and recorded in a global database, from which information is collected each year on international surveys.

This important 5th environmental action is implemented in the framework of the Strategy for Social Responsibility and in particular, in the framework of the “U & I Green” actions of the Tseti Pharmaceutical Group.The Green Team of Tsetis Pharmaceutical Group has sent the message that “Together we can and must protect the Environment and the marine ecosystem” .-

These two dynamiic actions, are part of the robust Strategy for Social Responsibility of the Tsetis Pharmaceutical Group of Companies and in particular of the U & I Care Program.

Uni-pharma & InterMed, pharmaceutical companies of the Tsetis Pharmaceutical Group of Companies (OFET) were awarded with 5 significant Awards,  at June11th 2020 at the Health & Safety Awards Ceremony, in Athens Greece. 

These 5 exceptional and significant distinctions, rank the Group very high in matters of Occupational Safety, Health and Culture. 

In addition, the Group received the Health and Safety Initiative of the Year award, as it collected the most points from all the awards it has won. 

Pharmabelle, the traiding company of OFET (Tsetis Pharmaceutical Group of Companies), celebrates and honors the World Environment Day, not only today June 5, but every day, through the whole year!

The other companies of Tsetis Group are the pharmaceutical companies Uni-pharma and InterMed, and the very new one UniHerbo!

Digital Science on the Go, took place in Athens Greece, at Uni-pharma laboratories, on Friday, 29th of May, 2020.

The R&D team of Uni-pharma & InterMed, companies of OFET (Tsetis Pharmaceutical Group of Companies) prepared an antiseptic and a supplement of Vitamin C. The digital Science on the Go, had the opportunity to watch it, students and professors. 

European Periodontal Day today, May 12, in addition to World Nurse’s Day.

Periodontal diseases are the most common diseases in European Community, but unfortunately, are the least recognized. Many patients are unaware that 80% of European citizens over the age of 35, suffering from some form of periodontal disease.

InterMed, company of Tsetis Pharmaceutical group (Pharmabelle in Cyprus) has specialized for daily care and professional use. You will find them in pharmacies.

The most crucial moment of the pandemic SARS COVID-19, Tsetis Pharmaceutical Group of Companies (OFET), with the InterMed industry, announced another donation to the Greece’s healthcare system.

The group’s management, in particular, handed over to the Ministry of Health (after free alcohol distribution by the Ministry of Development), more than 14,000 liters of antiseptic FREE, with specifications of the World Health Organization, which will be used purely for hospital use.

Tsetis Pharmaceutical Group of Companies, operates the pharmaceutical companies Uni-pharma, InterMed, Pharmabelle, the commercial company in Cyprus, and UnuHerbo the medicinal plant extraction company. 

Tsetis pharmaceutical Group of Companies (with the companies Uni-pharma, InterMed, Pharmabelle & UniHerbo) honors the environment and the plannet. 

OFET runs a dynamic Corporate Social Responsibility Strategy. Uni-pharma and InterMed as well, are proud members of UnGlobal Compact. 

Tsetis Pharmaceutical Group of Companies (OFET), with its companies Uni-pharma, InterMed, Pharmabelle & UniHerbo, wishing you Happy Easter. 

Even this Easter time it’s quite different and tough, because of the pandemic COVID-19, we have to be strong. That’s why we Stay Home, to be safe and healty. 

Happy Easter! 

Uni-pharma SA, the pharmaceutical company of Tsetis Group, which is represented by the Pharmabelle trading company in Cyprus, announces that donates in the Republic of Cyprus, directly 60,000 doses of Unikinon (the drug chloroquine).

It is worth noting, that Uni-pharma SA announced on Friday, March 27 2020, that it will release FREE 24 million doses of Unikinon to the Greek State and to the public hospitals.

The Greek industry announced that it purchased 5 tonnes of chloroquine from India on Saturday, March 21, 2020.

The production of the drug Unikinon is ready. Chloroquine, has been widely reported as a potential successful treatment for the coronavirus pandemic (SARS COVID-19).

Uni-pharma SA first received a chloroquine product license in Greece in 1984.

World Oral Health Day, today March 20. 

The message of the dentistis is strong: A healthy mouth means a healthy body. 

Pharmaceutical company InterMed, has in its portfolio innovative products for the whole family and for every oral problem, small, or bigger. Also pharmaceutical company Uni-pharma has in its portfolio the product Breath Clean, an antiseptic spray ideal for the oral health.

One year after the official announcement for the establishment of Be-Live, her first baby came into the world! Be-Live’s first child!

The couple’s first child who had been trying to live the family’s dream for years, and that dream came true thanks to the collective effort of all Be-Live people, but especially its creators, reproductive doctors Vasilis Kellari and Hari Chiniades.

On 27/02/2019 the two gynecologists had announced the establishment of the non-profit Be-Live Association with the main purpose of helping infertile couples who dream of having a child, offering their services for free. In a country such as Greece, with an ever-increasing birth rate and a steady decline in working population, Be-Live was created to provide prospects for infertile couples who cannot afford the cost of IVF therapies. 

InterMed, pharmaceutical company of OFET (Pharmaceutical Group of Tsetis Companies) supports the NGO Be Live. 

Corona virus (Covid -19). What recommends the Hellenic Society of Pediatric Hematology Oncology. 

Two very important Gold Awards, won Uni-pharma and InterMed (pharmaceutical companies of Tsetis Group of companies), on Saturday, February 8, 2020 at the 11th Health Expo in Athens.

These are Luxurious Sun care Invisible spray by InterMed and Uni-pharma’s Repel, which have been awarded gold medals following an Iatronet public vote.

The significant two gold awards, proves the potential of the brands to consumers.The consumers, can find all the products of Uni-pharma and InterMed, in all pharmacies. 

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Pharmabelle, the commercial company in Cyprus of Tsetis Pharmaceutical Group of Companies (OFET) participated in the conference, workshop and exhibiton Endocrinology, Diabetes and Metabolism held in Nicosia on October 19th 2019.

The participants, from Britain, Greece and Cyprus, had the opportunity to discuss interesting topics, such as Osteoporosis, obesity, diabetes.

The conference and workshop, was organized by the Ministry of Health of Cyprus, the Cyprus Medical Association and the Nicosia Hippocrates Medical Association.

It is worth to mention, that the conference was honored by his presence Prof Andrew Boulton the president of the International Diabetes Federation and past president of the European Association for the Study of Diabetes. The Prof.,  presented two pretty interesting studies according to diabetic neuropathy and diabetic foot.

OFET Group consists of two pharmaceutical industries: Uni-pharma S.A. & InterMed S.A. with more than 50 years presence and history, was founded, by the Visionary pharmacist  Kleon Tsetis. There is also the commercial company in Cyprus, Pharmabelle, that represents the pharmaceutical products and therapies of Uni-pharma and InterMed. In addition, a new facility for medicinal plant extracts, Uniherbo, is currently in its final stage of construction, Uniherbo, which will operate as a Research Institution and a science training hub for students and young scientists.

OFET’s vision is to lead a constantly changing pharmaceutical environment by providing high-quality (GMP), innovative, safe and effective products. 

.

.

In the beautiful island of Spetses started the 9th Spetses mini Marathon, which was implemented under the auspices of the Municipality of Spetses and EOT.

The InterMed Pharmaceutical Industry of Tsetis Pharmaceuticals Group has been vigorously involved in this important sporting event and even in the Kids Running and Swimming Sports Games – Baby Spetses Marathon 2019. 

InterMed with a long history in the field of medicine, always close to major sporting events as well as vulnerable groups of the population, made an appointment at the 10th anniversary of the Spetses Mini Marathon 2020!

.

Over 100 people, employees of Uni-pharma & InterMed industries, Pharmacy students of Greek Pharmaceutical Student’s Federation as well as journalists, were present on Sunday September 29, 2019 at the 11th Greece Race for the Cure in Zappeion, sending a strong message against breast cancer.
The Uni-pharma & InterMed Pharmaceuticals of Tsetis Pharmaceutical Group, through their dynamic running team of employees and under the scope of its Corporate Social Responsibility Strategy, as exclusive sponsors of the runners ran to honor the women who fight the disease, but also for those who left…
It is noteworthy that on the same day, 16 Race for the Cure eventstook place simultaneously in European cities. Crowds of people visited the Uni-pharma & InterMed booth to receive gifts and take pictures. Everyone made an appointment for next year!

.

.

The important two-day health, wellness and beauty activities organized by SYFAK (Association of Pharmacists of Crete & Dodecanese) in Heraklion, Crete, which took place on September 13 and 14, 2019, were supported by Uni-pharma & InterMed.
The two pharmaceutical companies – members of the Tsetis Pharmaceuticals Group are always close to the modern Greek pharmacist and his needs. 
Visitors had the opportunity to receive many gifts and samples of Uni-pharma & InterMedand to be thoroughly informed about all products.
 

For yet another year, the Uni-pharma & InterMed Pharmaceuticals of the Tsets Pharmaceuticals Group are meeting on Sunday, September 29, 2019 at the 11th Greece Race for the Cure in Zappeion, to send a strong message against breast cancer.
The two pharmaceutical companies will be there, with the moto “Together WE ARE ALWAYS WINNERS” and the Group’s dynamic running team of employees (OFET) under the scope of Corporate’s Social Responsibility Strategy.
In this way, Uni-pharma & InterMed are supporting the Panhellenic Breast Cancer Association of Greece, which is organizing the Greece Race for the Cure.
Recall that last year, along with the running team of OFET employees, Pharmacy students from the Greek Pharmaceutical Student’s Federation and medical reporters also participated.
At the 10th Greece Race for the Cure, about 40,000 participants ran and walked (according to the organizers), while the Race was held under the aegis of SA. by the President of the Republic, Mr. Prokopios Pavlopoulos.
Registration for the 11th Race Greece Race for the Cure begins on Friday, August 30th.
Be there!

The AMKE Foundation for Cleon Tsetis, created by the OFET Group, actively supports science and the younger generation.

As part of its ongoing support and support of educational and research activities, it recently sponsored a botanical excursion to the Pharmacognosy and Natural Chemistry Laboratory of the EKPA Department of Pharmacy, led by Professor Leandros Skaltsounis. The botanical excursion took place in the Athamanian Mountains, better known as Tzoumerka. The great biodiversity of Tzoumerka have led to the incorporation of parts of the wider area into the botanical study and exploitation program of the Department of Pharmacognosy and Chemistry.

The objectives of this activity were to search for plant material of medicinal interest, to identify and record endemic and non-plant species in the southern part of the mountain. Specimens of 32 plant species were also collected with the aim of integrating them into research studies, the results of which may lead to the discovery, emergence and further exploitation of domestic flora for the production of high quality products. value added (cosmetics, nutritional supplements or even pharmaceuticals).

In this botanical excursion, which was led by Professor Leandros Skaltsounis and the expert on systematic botany Dr. Eleftherios Kalpoutzakis, participated 42 participants, mainly postgraduate students and PhD candidates of the Department of Pharmacy of the University of Athens, professors, foreign researchers and other associates.

The Cleon Tsetis Foundation actively supports science and the younger generation and implements actions aimed at upgrading the infrastructure of the country’s educational institutions.
In this context, the renovation of two open air spaces with aromatic and medicinal plants in the NCSR – the university’s Department of Pharmacognosy and Chemistry – is also part of the renovation, with the aim of enhancing the work of the academic community and upgrading the level of education of young scientists.

Note, as recently pointed out by the President and Managing Director of the OFET Group, Ms. Julia Tsetis, receiving an award at the DIAMONDS OF THE GREEK ECONOMY 2019 event – on 10 July 2019 – the Group plans to launch a 4th unit Extracts of medicinal plants and will also function as a Research Institute for students and young scientists. The aim is also to carry out a continuous study of the country’s biodiversity by scientists and students.

OFET was honored with 6 awards and Honors to the Managing Authority as part of the BEST IN PHARMACY 2019 event, organized by the Pharmaceutical World and the Boussias Communications Group on Monday, 15/7/2019. The event rewarded the best business practices in the business and pharmaceutical sectors.

In particular, Group Ceo Mrs. Julia Tseti and Group CFO Mrs. Irene Tseti received an honorary prize for their total contribution to the pharmaceutical and business sectors.

Mrs. Ioulia Tseti, referred to  OFET Group dynamic, which insists on staying in Greece, investing, innovating and supporting both the labor market and the pharmacists’ industry. In the years of the Greek economic crisis, the pharmaceutical companies of Uni-pharma and InterMed and the trading company Pharmabelle, in Cyprus, tripled their job offering by investing significant amounts in Greece and abroad.

Mrs. Tsetis also referred to the new plant of the Group, Uniherbo plant, which will also function as an Institute for the Study of Young Scientists and will record the biodiversity of the country.

 

The remaining awards from BEST IN PHARMACY 2019 are as follows:

• InterMed S.A. GOLDEN PRIZE – Top sales team at the drugstore – DREAM TEAM – SELLING GROUP InterMed – Antonis Zepos.
• UNI-PHARMA SILVER PRIZE – Top launch of a new pharmacy product (Diet supplements – Superfoods – Vitamins – Dietary products) D3 fix & D3fix + K2 – Constantinos Aphegenis.
• InterMed S.A. SILVER PRIZE – Top launch of a new pharmacy product (Cosmetics) LUXURIUS SUNCARE INVISIBLE SPRAYS – Vlassia Aroni.
• InterMed S.A. SILVER AWARD – Best marketing campaign for large budget pharmacy products LUXURIOUS SUNCARE – Myrto Raptis
• OFFET – SILVER PRIZE – Best pharmacy product of the year in the field of Corporate Social Responsibility – U & I CARE, SOCIAL RESPONSIBILITY STRATEGY – Victoria Michaelidou

.

Another important award was received by OFET Group, Tsetis, at the DIAMONDS OF THE GREEK ECONOMY 2019, organized by New Times Publishing on Wednesday 10/7/2019.

The Group was rewarded for its performance in the Economy and Sustainable Development, with a worth mentioning augmentation of job offerings, extroversion, investment, responsible sustainability and ethics.

The prize was received by the President and CEO of OFET, Mrs. Ioulia Tsetis.

 

With the award of “Centenarian brand 2019” for the product Salospir, for its 33 years of presence in the pharmaceutical market, Uni-pharma Pharmaceutical Industry was awarded on 26/6/2019.

The award was received by the Marketing Manager of Uni-pharma SA pharmacist Mr. Markos Theodorou.

SALOSPIR is a product of independent research and know-how of the Uni-Pharma Pharmaceutical Industry since 1986, when it was first released. It has as active ingredient acetylsalicylic acid in the form of enteric-coated tablets, so as to protect the stomach from the irritant effects of acetylsalicylic acid.

It is a product, which effect has been proven through clinical studies, that can provide the necessary preventative treatment as anticoagulant and platelet antiplatelet. which in simple terms means prevention of myocardial infarction both preoperatively and postoperatively.

Salossir, in 2018, sold 10 million units, only in Greece, with growth over 3% over the previous year. It is also worth noting that in 2018 over 550,000 Greeks were in daily treatment with SALOSPIR for the whole year.

Uni-pharma is the first pharmaceutical company in Greece, which in 1996 has made a major investment to introduce environment-friendly technology by purchasing new technological equipment specifically for the coating of SALOSPIR enteric coated tablets, for which it was honored by the Ministry of Pharmaceutical Industry with the award of the 3rd Prize for “Environmentally Friendly Production Methods and Products”.

Salospir was also distinguished in 2003 by the EMEA, with the “2003 Named Product Award”.

For the course of its business’s extroversion , Uni-pharma pharmaceutical company was awarded at the “Leaders of the Greek Economy”on Monday 10/6/2019.

The prize was received on behalf of the administration led by Mrs. Ioulia and Irene Tseti and the International Sales Manager Mr. George Spigos

Bold investments of more than 80 million, three factories, renovation of Uni-pharma’s first historic factory, intense extroversion in more than 64 countries with brand names by Uni-pharma and InterMed and over 500 employees, of which 57% highly skilled and 38% women. It is worth noting that over the last three years (2015-2018), the Group has increased its employees by 150.

Some of Uni-pharma’s well known formulations are Apotel, Salospir, T4 as well as Trebon Grippe, Trebon Grippe day & night and Repel.

OFET’s investment plan for the next three years 2019-2021 exceeds 15m euros, with the completion of the radical renovation of its first and historic plant on Lamia National Road and the creation of a modern Logistics Center.

In addition, a new unit of medicinal plant extracts called Uniherbo is being prepared, which will also act as a study institute for the education of students.

The event was organized with the support of Piraeus Bank, while the institution is under the auspices of the Ministry of Economy and Development and the BSE.

The dynamic Green Team of OFET, was found for the second year on the weekend of 8 and 9 June 2019 in Mykonos to clean the seas and coasts (underwater and offshore).

The Voluntary Group of 20 people worked under the expert guidance of the voluntary organization All for Blue headed by Mrs. Katerina Topouzoglou and the full support of the Port Authority of Mykonos.

The OFEF headquarters headed by Mrs. Ioulia and Irene Tsetis are very grateful to the Port Authorities and the Port Authority, Mr. Panagiotis Katsaras, who has made it very easy with this group to facilitate this important action.

The OFEF Green Team cleaned the beaches of Ftelia and Caparis from plastics and other litter that pollutes the shores and the aquifer, thus wanting to give a strong signal to protect the environment.

It is worth noting that this “green” action is part of the Social Responsibility Strategy of Tsetis Pharmaceuticals Group, in particular its environmental dimension, U & I Green, Uni-Pharma & InterMed.

 

The OFET Group celebrates the World Environment Day (5 June 2019) not only one day but all year, with a series of important actions.

Actions that respect the ENVIRONMENT, under the umbrella of the U & I Care Corporate Social Responsibility Strategy, with 530 employees, have fully embraced the culture of administration.

All three industrial / production units of the Group (two of Uni-pharma and one of InterMed) have been created with the aim of utmost respect for the environment.

The recent creation of OFET, the Uni-pharma bioclimatic building in Kifissia, is already showing the path of sustainable development and green logic, with insulation on its surfaces to reduce noise and reduce energy consumption and natural resources, especially water and Natural Gas. The plant has been built to have a south-eastern natural orientation to exploit natural light in order to reduce the consumption of electricity.

All three plants have a responsible waste management, whereby the waste is shipped either for destruction to overseas units or to TITAN for alternative fuel production. In all units, there are particulate retention filters (on chimneys) to protect against air pollution.

The same applies on the management of water and waste water. The specific wastes are not directed to the sea but are destroyed through a special waste management form in order to perfectly protect the aquifers.

It is worth mentioning that there is a collective waste management system sorted by source. In general, there is responsible waste management and soil protection. It is remarkable that the equipment of the employees is environmentally friendly, with the aim of reducing the environmental footprint.

Also, recycling programs are being implemented at the premises of the Group’s companies, with the participation of employees and the use of special recycling bins placed in the workplace for this purpose, within the framework of the “U & I Green – Uni-Pharma & InterMed” .

Environmental awareness and awareness among workers is demonstrated daily through proper motto training:

• “YELLOW = PAPER RECYCLING”
• “GREEN = PLASTIC & NYLON RECYCLING”.
• “RED = GLASS RECYCLING”
• “COFFEE = WOOD RECYCLING” (New Action 2018).
• “BLUE = ALUMINUM RECYCLING” (New Action 2019).

 

Save the Sea action

For the second year, Green Team of OFET employees will be found on Greek islands for underwater and offshore cleaning to clean the seas and coasts with the slogan “Save the Sea” and in collaboration with NGO All for Blue. The first station is Mykonos, which will be visited by the Green Team of OFET at the weekend of 8 and 9 June 2019.

Finally, the pharmaceutical companies of OFET and the Group as a whole have been distinguished seven times for their environmental sensitivity.

 

.

The OFET Group will participate in Healthplex Expo 2019 Natural & Nutraceutical Products China 2019 with the pharmaceutical companies of Uni-pharma & InterMed.

The exhibition will be held from 19-21 June in Shanghai.

The dynamics of exposure are reflected in the following elements:

• Exhibition space of 140,000 sqm, 1,800 exhibitors, 100,000 buyers and more than 60 countries.

Uni-pharma and InterMed with their innovative products and with a long history and tradition in the field of pharmaceutical and healthcare are always close to the patient and his needs. The mission of both industries is to produce domestically high-standard (GMP) innovative formulations for treatments that improve the quality of life of patients.

World Thyroid Day was celebrated on May 25th, and it is very important that we are all sensitized to a health problem that often does not have very strong symptoms, or some of our symptoms get confused.

It is estimated that 60% of those with thyroid dysfunction do not know they have a problem, while women are 5-8 times more likely to have thyroid-related diseases.

Either a person suffering from hypothyroidism (with symptoms such as tiredness, constipation, dry skin, hoarseness, muscle pain, depression, etc) or hyperthyroidism (with symptoms such as sudden weight loss, tachycardia, increased appetite, trembling, sweating difficulty sleeping etc) Doctor is the right person to look at and check what exactly is happening.

Uni-pharma and InterMed, pharmaceutical companies of the Tseti Pharmaceutical Group with long experience, knowledge and expertise in thyroid diseases, with a range of innovative formulations and therapies, are always close to the patient and his needs.

Mission Life (Strategic Program in the Corporate Social Responsibility of the Tseti Pharmaceutical Group) travels frequently to the province and to remote areas and, in cooperation with the Hellenic Endocrinological Society, implements preventive examinations.

OFET is officially the Gold Leading Organization for Excellence in the Pharmaceutical Sector, supporting the electronic version of the EFQM Model in the Greek language (https://www.efqm.org).

OFET, with the pharmaceutical companies Uni-pharma and InterMed and Pharmabelle in Cyprus, has been applying the EFQM Model of Business Excellence systematically since 2008 in areas including – Leadership, Human Resource Management, Processes and Financial Results .

By taking a further step, OFET becomes an ambassador of business excellence and, in collaboration with EFQM and EEDE, offers free of charge the electronic version of the Model in Greek, thus encouraging other enterprises, industries and organizations in our country to implement it. Through this initiative, the Group shows the path of growth, the extroversion of diversity, the stamp of credibility, equality and excellence!

The 21st European Conference on Endocrinology (ECE 2019: 18-21 May 2019) was held at Lyon, France, in particular at the Center de Congrès de Lyon.

OFET Group, with long experience and expertise in thyroid diseases, participates in this important exhibition with a brilliant and modern pavilion.

It is worth mentioning that Uni-pharma has blockbuster products for thyroid treatment. It is worth noting that T4 is a specialized product available in 13 different contents in individual dosage regimens.

The conference, considered a world-class reference point for endocrinology, employs more than 3,700 representatives from more than 90 countries. During the conference, the latest endocrine research and developments are expected to be discussed with a view to improving the quality of patients’ life. 

May is already here and asks us to care for and protect our skin.

The sun has already begun to burn, and now it’s time to start using the InterMed’s Luxury brand Luxurious sunscreen creams for the protection and beauty of our skin.

An advanced series for face, body and hair. You will find the brand at pharmacies, by InterMed, the pharmaceutical company of Tsetis Group of Companies.

 

Uni-pharma is the only Greek pharmaceutical industry to participate in the PRIX GALIEN 2019 global pharmaceutical prestigious prize.

The Greek pharmaceutical industry participated in the “Best Pharmaceutical Product” category, with TREBON GRIPE day & night.

 

TREBON-GRIPPE® day & night (now in the DISY list) is a dynamic and innovative formula, targeted at colds and flu-like infections. It is an innovative drug with 5-fold action, consisting of a combination of active substances in the form of effervescent tablets.

TREBON-GRIPPE® day & night is available in the form of effervescent tablets with a different formulation for use during the day (“TREBON-GRIPPE® day”: 500 mg paracetamol, 200 mg acetylcysteine ​​and 40 mg pseudoephedrine hydrochloride) and overnight “TREBON-GRIPPE® night”: 500 mg paracetamol and 4 mg chlorphenamine).

TREBON-GRIPPE® day & night is indicated for the short-term treatment of colds and flu-like infections associated with the formation of mucus viscosity in the respiratory system and accompanied by fever, joint pain and stuffy nose.

Following the legacy of a historic drug of TREBON, the 2nd generation of scientists and the R & D division of the Uni-pharma pharmaceutical industry went one step further, creating Trebon Grippe day & night to cover the patient during afternoons and evenings hours. Thus, with TREBON GRIPPE day & night, the patient is even more strengthened as the formulation also contains the antipyretic and analgesic active substance paracetamol and chlorphenamine maleate, which soothes cough, favors sleep and at the same time also has anti- allergic action.

 

The innovation of TREBON GRIPPE day & night

The innovation of TREBON-GRIPPE® day & night is based on a combination of active ingredients, able to meet the different therapeutic needs of the patient arising during the day and night.

The strategic choice of UNI-PHARMA PHARMACEUTICAL LABORATORIES SA for the creation of TREBON-GRIPPE® day & night was aimed not only at the complete treatment of patients from the unpleasant symptoms of cold without taking multiple formulations, but also in significantly improving the compliance of patients.

The 40 students of the University of Patras Pharmacy have had the opportunity to visit Uni-pharma’s bioclimatic plant, a state-of-art unit for Greece and Europe, to see the modern robotic systems, the dynamic Research and Development (R & D) ) and to clearly understand all stages of the formulation and packaging of pharmaceutical preparations.

The chairman and CEO of OFET, Mrs. Ioulia Tsetis, a pharmacist herself addressed to the students, spoke with great interest and warmth for the profession of pharmacist and the science of pharmacy. She believes that future pharmacists should demonstrate consistency, dedication and loyalty to their profession, but also to the patients on a daily basis. Mrs. Tsetis also referred to the pharmaceutical industry as an extremely dynamic branch of the Greek economy and industry, which fully supports society and the labor market.

OFET Group supports science and the young generation in every way as an integral part of its actions on Corporate Social Responsibility. Indeed, AMKE KLEON TSETIS – which was created in memory of Kleon Tsetis – provides scholarships to young scientists who contribute to science, research and art.

The most historic medical conference in Cyprus was supported a few days ago with the presence of the Tseti Pharmaceutical Group.

The 39th two-day conference of the Medical Association of Limassol was held on 6 and 7 April 2019.

During the conference, the latest developments on major scientific issues were discussed, communicated and exchanged.

The Tseti Pharmaceutical Group, with the pharmaceutical companies of Uni-pharma, InterMed and the pharmaceutical company in Cyprus Pharmabelle, had a strong presence in the conference.

OETT, with over half a century of history, with more than 500 employees, exports to more than 60 overseas markets and innovative medical formulations, is always close to the patient and his needs, servs health and patients.

“Together we are always winners,” the Running Team of OFET, on April 7, 2019, ran along with hundreds of people in the 2nd Dental Run at Goudi Park.

On the World Health Day, Uni-pharma & InterMed Pharmaceutical Industries of OFET were great sponsors of this beautiful race, and ran to deliver the message healthy body & healthy mouth. A healthy body is and remains healthy when we also have a good oral health.

The 2nd Dental Run, organized by the Athens Dental Students ‘Association – ADSA, the Greek Pharmaceutical Students’ Federation – GPSF and the Municipality of Zografou.

Along with the race, the runners were informed on the steps of good oral health and received useful gifts with the signature of InterMed.

Athens, April 5, 2019. Another award for the CEO of the Pharmaceutical Group (OFET), who celebrated on Thursday, April 4th, at the CREATIVE GREECE 2019 annual awards organized by the New Times Publishing at the Hilton Hotel.

The Group’s President and Managing Director, Mrs. Ioulia Tsetis, received the award, noting, among other things, the following:

“In the years of the Greek recession, OFET with the industries of Uni-pharma & InterMed resisted vigorously, investing over 80 million euros.

Today, the Group employs more than 500 employees, has already begun implementing a new investment plan of 15 million euros for the three-year period 2019-2021, while exporting to more than 60 demanding foreign markets. “

Mrs. Tsetis also announced the creation of a new unit of medicinal plant extracts, Uniherbo, in the Inofyta area, which will also be a study institute with an educational character for students.

Mrs. Ioulia Tsetis received the award from the Vice President of the Greek and Industry Association Mr. Konstantinos Bitsios.

.

The Pharmagora 2019 International Exhibition held in Paris on 30 and 31 March was attended by OFET Group.

This is a very important international event (held at the Paris Expo Porte de Versailles, Paris, France) for all industries and businesses dealing with medicine, parapharmaceuticals, research, development and holistic pharmaceutical and pharmaceutical medical approach.

According to the organizers, the exhibition was estimated to have about 13,021 visitors, while 403 exhibitors participated.

OFET with the pharmaceutical companies of Uni-pharma & InterMed is always close to the events, having a long track in the pharmaceutical field as well as in the international environment with exports to more than 60 countries.

 

The Group of Tsetis Pharmaceutical Companies of Tseti (OFET), awarded at the Health & Safety Awards Ceremony organized by the Boussias Communications Group, on Tuesday 27 March 2019.

In particular, the Group distinguished:

In the section: Activities at Facilities and Activities at Work Establishments, with Silver Award for UNI-PHARMA’s new modern Bioclimatic Building. The prize was received by Mr. Vrettos Michalis, Facilities Supervisor.

In the section: Corporate Health & Safety Culture Activities / Activities for Building Health & Safety Corporate Culture with Bronze, for Education and Raising Awareness of OFET Group on Health and Safety issues. The award was received by Mrs. Liokalou Maria, Quality Assurance & Environmental Health & Safety Manager.

And finally,

In the section: Companies & Organizations, Highly Commended for Health and Safety in the OFET Group. The award was received by Mr. Georgopoulos George, Safety Officer.

.

.

.

The administration of the Group of Pharmaceutical Laboratories Tsetis (OFET) with the pharmaceutical industries Uni-pharma, Intermed and the merchant company of Cyprus Pharmabelle, welcomed a team of chemists and journalists from Cyprus on Friday 22nd of February, at the facilities in Kifisia.

The visitors were guided at their contemporary facilities where they had the chance to see the new bioclimatic industry of Uni-pharma – which functions properly from 2015- and to discuss in person the business plans of the administration headed by misses Ioulia and Eirini Tseti.

Nowadays production facilities of Uni-pharma, which use the latest technology, with robotic systems and advanced security level, result from the extension of the previous facilities, thanks to the biggest investment to a sum of 35 million euros that took place in our country the last years, in the middle of the worst postwar recession that Greece has met.

Investments, extroversion, economic data

With three new contemporary production industries, the Group of the Pharmaceutical Laboratories Tsetis, has impressively good results of development, having invested more than 80 million euros the last years.

With the three-years investment plan (2019-2021) outreaches 15 million euros with the completion of the renovation of the first historical industry of Uni-pharma, at Ethniki Athinon Lamias.

At the same time, a new ultramodern logistic center with the same owner is created and it will serve the requirements of the second industry of the laboratories, of the pharmaceutical InterMed.

The Laboratories industries export at 61 markets abroad, having as their emblem the necessity for extroversion and national orientation, a necessity for the development of Greece.

Today, the Group of the Pharmaceutical Laboratories Tsetis, occupies more than 500 employees, while the last three years (2015-2018) the staff was increased by 150 new positions.

The merchant PHARMABELLE is founded in 2014 in Cyprus, with an interest in offering innovative pharmaceutical and para- pharmaceutical products for the Cypriot and international market.

It also represents the famous pharmaceutical industries of Uni-pharma and InterMed and develops strategic cooperations with suppliers and companies with high standards.

 

Responsibility for the society

The Group of Pharmaceutical Laboratories Tsetis, are appeared especially dynamic in the social action field, supporting vulnerable social groups and remote areas, through the significant action of LIFE MISSION.

This action integrated in the strategic program of Corporate social responsibility of the Group of OFET. In particular, the Group of Pharmaceutical Laboratories Tsetis, realize in corporation with the local Medical and Dental Associations, preventive medical and dental screening tests, while all the employers support actions for the Environment.

Moreover, OFET, enforce the CNPC- Civic Non Profit Company of Kleon Tsetis (dedicated to the memory of the creator of industries, dearly departed Kleon Tsetis, restless chemist and explorer) which is the most critical moment social actions, aiming to support the university, investigative and scholar society but also the new generation of scientists. The CNPC Kleon Tsetis loyal to the dream of its founder and to the encouragement of knowledge and the new generation, support with internships new scientists from the field of pharmaceutics, Medicine and art. In the end of 2018, the CNPC Kleon Tsetis signed a cooperation covenant with Axion Hellas, in order to be more closely to the vulnerable social groups.

 

Research- Development and Distinctions

A company like the Group of Pharmaceutical Laboratories Tsetis, with two important industries, it’s reasonable to aim the research and the development, spearheading our production.

From 2018 until today, we have handed in 9 new applications for patent degrees as well as 26 national and 12 European patents.

The industries Uni-pharma, InterMed and the bioclimatic industry of Uni-pharma, which is a “diamond” not only for the Greek industry but also for the whole Europe, have many distinctions and awards-  national and international.

Among the distinctions that Pharmaceutical Laboratories S.A has received is the national certification of business excellence of 5 stars EFQM and Investors in People International.

Furthermore, Uni-pharma as well as InterMed are proud members of the United Nations Global Compact.

.

.

.

.

Tsetis Pharmaceutical Group (with the pharmaceutical companies Uni – Pharma & Intermed) participated at the largest Dental event in the wider Mediterranean and Saudi Arabia region, AEDDC.

The central title of this year’s exhibition was “Education & Innovation Transfer,” while over 150 international and local speakers spoke in the framework of the international exhibition.

It is noteworthy that more than 2,484 exhibitors were hosted in the exhibition, presenting their latest technologies and products.

Tsetis Pharmaceutical Group, could not miss such an important event. With the strong product portfolio, Uni – Pharma & InterMed made a strong presence in a booth that was visited by lot of people and potential collaborators.

.

.

For 11 years in a row, the pharmaceutical companies Uni-pharma and InterMed have supported the successful scientific presence of ENDORAMA.

The important scientific event took place during the weekend of 25-26 January 2019 at the Conference Center of the University of Patras.

The conference presented newer therapeutic and research developments in Endocrinology, Diabetes and Metabolism.

This year the number of foreign speakers has increased and a new section for nutrition has been added.

Uni-pharma & InterMed, with a sense of responsibility, support every venture that links science with research and new therapies for the benefit of patients.

The pain from osteoarthritis is unbearable.

Osteoarthritis is the most common form of arthritis. It is a chronic disease that has occurred people over 65 years old.

It is estimated, that 3 in 4 of those age, suffering from this chronic disease.

The Uni-pharma pharmaceutical company of  Tsetis Pharmaceutical Group, has a very strong solution: The treatment BEST: Relief treatment of the symptoms of osteoarthritis, powder for oral solution: 1.884 (1.5) g / sachet.

BEST by Uni-pharma and do not let osteoarthritis block your every day movements …

.

Microbial infections of the feminine intimate area are very disturbing.
InterMed innovates once again in the market, with a highly innovative product line.
EVA mycosis brand with boric acid and tea tree oil consists of EVA Mycosis Ovules, EVA Mycosis Intimate Foaming Wash, Eva Mycosis Intimate Wash, Eva Mycosis Intimate Spray.
Products specifically designed to control fungal infections.
In particular, EVA Mycosis Ovules inhibits fungal activity within 48 hours and over 90% while balancing the vaginal environment.
Eva Mycosis Intimate Spray, Eva Mycosis Intimate Foaming Wash and Eva Mycosis Intimate Wash can be combined with medications to treat fungal infections of the genitals and are recommended for dermal use in other parts of the body.

It is worth noting that Eva Mycosis was awarded last year with the Best in Pharmacy Gold Award as the most innovative new pharmacy product!

Read more on the link below:

https://intermed.com.gr/el/taxonomies/mikroviakes-loimokseis

A wonderful moisturizing and remedial hand cream that you will not stop using! The pharmaceutical workshops of InterMed once again makes the difference, with Eva Belle Intensive Hand Treatment Cream. It is a rich hand cream for intensive nourishment, hydration and repair of very dry and cracked hands. It is not a simple cream, but a rejuvenating cream, intensive nutrition.

Eva Belle Intensive Hand Treatment Cream has a very rich composition that makes it an ideal choice for very dry and cracked hands. The essential components of the composition that offer the protection and remediation of the skin are silk proteins, curry butter, allantoin, hyaluronate and aloe. Try it today!

Uni-pharma and InterMed are the only pharmaceutical companies among 30 businesses in Greece, which signed on 21 January 2019, the establishment of the Global Compact Network Hellas.
Global Compact Network Hellas is the United Nations Global Compact (UNGC) Local Network in Greece.
Among its objectives are the promotion of UNGC principles in the areas of human rights, industrial relations, the environment and the fight against corruption, promotion of responsible entrepreneurship practices among Greek companies, contribution to the further development of the UNGC initiative , influence on national policies for responsible entrepreneurship and mobilization of enterprises to contribute to the achievement of Sustainable Development Goals.
It is noted that since 2008, when the Global Compact Network Hellas National Declaration was presented by 2019 and the legal entity was established, CSR HELLAS was coordinating its actions.
Global Compact Network Hellas promotes the initiative of the Global Compact and its 10 Principles in Greece. It cooperates with the UN Global Compact in New York and acts as its local contact point for Greek members of the initiative. UN Global Compact is a norm for businesses to align their operations and strategies with 10 globally accepted Principles in the areas of human rights, working conditions, the environment and the fight against corruption.

The feminine intimate area needs special care and attention.

InterMed Pharmaceutical Laboratories with its vast experience knows this well. That’s why it offers 18 unique products aimed at all the needs of modern Eve.

Read more at the link below: https://intermed.com.gr/en/brands/eva

If you are on the computer for many hours and feel your eyes dry or irritated, then you need urgent targeted care.
Optofresh forte, optofresh relax, optofresh towles, Optonic, a complete range of InterMed’s pharmaceutical laboratories products. Seven products designed for high needs for your precious eyes. Whether you are in the office, working outdoors or traveling, InterMed has the most reliable solution.
Read more on our page: https://intermed.com.gr/en/taxonomies/ofthalmologika-proionta

.

A winter weekend is in front of us and our eyes are closing, and some of us, planning an excursion, or a trip to the snow.
But what if our first thought is nausea and we can not enjoy the beauty of the journey?
Uni-Pharma Pharmaceutical Company has the most reliable solution that helps relieve the nausea of ​​travelers.

TravelFix. The Travel fix diet supplement, thanks to the Ginger Herbal Extract containing (500 mg Ginger per tablet), helps relieve the nausea that occurs during travel. Moreover, it does not cause drowsiness and does not contain preservatives.

• Do not exceed the recommended daily allowance
• Food supplements should not be used as a substitute for a balanced diet
• This product is not intended for the prevention, treatment or cure of a human disease. Consult your doctor if you are pregnant, breast-feeding, undergoing medication or experiencing health problems.
• Keep out of the reach of children

There is nothing more beautiful than the perfect-shaped eyebrows and thick eyelashes.

InterMed has the solution: Eva Belle Eye Brow Enhancing Serum. A serum that strengthens eyebrows and eyelashes.

• With Argan oil, coconut oil & Provitamin B5 & a clinically proven molecule from basil extract that helps to reduce hair loss.
• Ophthalmologically and dermatologically tested.

 

Instructions for use:

• Eyebrows: Apply to clean eyebrows, once a day.
• Eyelashes: Place a small amount on your fingertips and apply it to the lashes.

 

Eva Belle Eye Brow Enhancing Serum: For a Magnifying Look !!

.

.

.

A brilliant event took place on Friday, January 4th, in order to celebrate the new year.

During the event, employees had the opportunity to exchange wishes and also to discuss with the administration about the new 2019 targets.

In her speech, the chairman and managing director of the Group, Mrs. Ioulia Tseti, thanked the staff for their significant contribution to the growth of the companies and asked the staff to show faith, dedication, self-improvement and accountability in 2019.

Mrs. Tsetis also mentioned the important social activities of the Group. Specifically:

The ‘AMKE KLEON TSETIS’ Foundation, which is a focal point of social actions, aiming to support the academic, research and academic community as well as the new generation of scientists.

Also the ‘Apostoli Zois’, another remarkable social action that travels to every remote part of the country by carrying out preventive medical and dental examinations.

The chairman & CEO of the Group also referred to the need to raise awareness among all employees of environmental actions for the whole of 2019.

Good and creative year for all !!

.

Pharmabelle wishes you  a Happy Year with health, joy, optimism, peace and prosperity!

Let us all work quietly and creatively in order to achieve our realistic and ambitious goals.

.

.

.

.

.

.

.

.

.

Uni – Pharma is the golden sponsor of the publication “The Hippocratic Oath” and its translation into Chinese.. With this symbolic move,  Uni – Pharma demonstrates the relations between Greece and China, both in economic, commercial and health terms.

The Chinese edition of the ‘Hippocratic Oath’ was presented at an event in Shanghai, in November 2018. ​​Mr. Dimitris Mihas from the Greek Embassy, representatives of Chinese companies from the wider health and pharmaceutical sector, the President and Managing Director of Uni-Pharma Mrs. Julia Tsetis attended the event.

During her speech Mrs Julia Tsetis stated: “The Hippocratic oath, the doctors’ oath all over the world is not just about the moral practice of medicine. It’s a lot more! It is addressed to every thinking person who wants to follow in his life, the path of Ethics, Justice, and Human Values. Such societies must be built, such societies deserve us.

Let us continue our historical journey through the ages, and the road of silk, to become a path of knowledge, morality, modern technology and excellence, aiming at the uninterrupted supply to the community. “

Mrs. Tseti concluded her speech, mentioning the importance of Hippocrates’ basic principle, that a person can only be healthy when living in a healthy society.

Uni-Pharma, InterMed Pharmaceutical Industries & a Cyprus-based company of the Tseti Pharmaceutical Group, Pharmabelle, had a dynamic participation in the the 9th Pancyprian Gynecological Congress

The Conference was held on 17 and 18 November in Larnaca (at the Palm Beach Hotel), organized by the Pancyprian Gynecological and Obstetric Society and the Greek Delegation of the British Royal College of Obstetricians and Gynecologists.

The conference was held under the auspices of the Minister of Health of Cyprus.

The conference is organized every two years, in a different city of Cyprus, and is the leading event of the Pancyprian Gynecology and Obstetrics Society.

In addition to scientific issues, workshops on urogynology were also held in the two-day conference.

Pharmabelle, Uni-Pharma & InterMed with a range of innovative products are constantly close to the patients and meet their needs in order to improve their quality of life.

The 5th Pancyprian Internal Medicine Conference, held at the Hilton Park Hotel in Nicosia on 1st &2nd of December, was supported by Pharmabelle, a company of the Pharmaceutical Companies Group (OFET) in Cyprus and the Uni-Pharma Pharmaceutical Industry of the Group.

 The conference was organized by the Cypriot Society of Pathology, aiming to present latest trends, scientific studies as well as exchanging views and experiences on pathology issues.

Uni-pharma, with over half a century of experience, has been close to the scientific community and to the patients in order to improve their quality of life.

.

Another important voluntary activity was carried out by InterMed, a pharmaceutical company of the Tseti Pharmaceutical Group  in cooperation with the Dental Association of Arta, on the 1st and 2nd of December.

The action was a great success, as 110 patients, including many children, were examined in two days.

All patients were given instructions for oral hygiene and dental care products.

In the event, all members of the Dental Association of Arta participated with great willingness.(maxi-surgeon, pediatric dentist, orthodontist and general dentists).

InterMed has implemented this action within the framework of the Corporate Social Responsibility Strategy and in particular the “Mission of Life”, which aims at strengthening vulnerable groups in borderline and remote areas.

At the 32nd Postgraduate Meeting organized by the Hellenic Endocrinology Society – Pan-Hellenic Association of Endocrinologists (UIE-PEE), Uni-pharma & InterMed, pharmaceutical companies of Tseti Pharmaceuticals Group, participated with two separate stands.

Cognitive speeches were selected to cover cognitive subjects and the latest data from the recent Pan-European Diabetes Congress (EASD-2018) were presented.

Uni-pharma & InterMed represent a dynamic presence in medical and healthcare activities, actively supporting the scientific community that in turn supports the Greek patient and his needs..

.

.

At the 30th International Symposium on Natural Products Chemistry and at the 10th International Conference on Biodiversity (ISCNP30 & ICOB10) held from 25 to 29 November at the Royal Olympic Hotel, OFET participated with the two pharmaceutical companies of Uni-pharma & InterMed, sending the message that it has a strong presence in the field of herbal preparations.

The Group’s products in the field of herbal formulations are Olivomed & Herbofix.

Olivomed® are soft capsules rich in polyphenols. They contain Greek virgin olive oil of Koroneikis variety and standardized olive oil extract Amfissis that offer antioxidant, anti-inflammatory and anti-atherosclerotic properties.

With 2 soft capsules a day, it helps prevent atherosclerotic plaque formation and protects HDL lipoproteins from free radical attacks. It does not contain sodium and salt, it has no bitter taste and extra calories and its low in sugar.

Herbofix are capsules, compatible with Nespresso® machines, have multiple properties and a wide range of choices: Herbofix Respiratory to feel better in the moment, Herbofix Energy to stimulate the body, Herbofix Relaxation to relieve anxiety and insomnia and Herbofix Digestion ideal for after meals and for any moment in the day!!

.

.

The value of prebiotics for our health not only for the good function of the bowel but also for the prevention of chronic diseases was once more pointed out during the speech of the professor of Pathology in the 4th Pathology clinic of the medical school of the National and Kapodistrian University of Athens, Evaggelos Giamarellos-Mpourmpoulis,  in the context of the 8th Pancypriot Pharmaceutical Congress.

The congress was held at the weekend of 17 and 18 November in Nicosia and Pharmabelle , the commercial company of the Tsetis Pharmaceutical Business Group, declared their presence strongly , at the same time supporting the Professor’s speech.

As stated by Pr  Giamaraellos among others in his speech, “the word “prebiotics” is an accurate translation in Greek of the anglosaxon word probiotic and it comes from the prefix “pro” which means “for” and the word “viosi” which means “life”. Therefore, prebiotics are still bacteria or fungi that if consumed in sufficient quantities help in the better quality of living or protect life. The prebiotic bacteria use lactic acid as their nutritional content and for this reason they are known as lactobacilli. Their significance has been proven by a revolution in our knowledge for the understanding of chronic diseases. The last 10 years we have learned that in our bowel reside almost 1 billion different microorganisms per bowel grammar with which we live in harmony .”

And the professor went on, “the success of therapy with prebiotics, is based on an essential  condition; the pharmaceutical formulation that will be administered should resemble as much as possible the “ecosystem” of the bowel. For this reason, pharmaceutics that contain more than one prebiotics should be prescribed, exactly like the “microvioma” (good bowel bacteria) consists of more than one microorganisms. Also, the pharmaceutics administered should contain the quantity of billion prebiotics exactly like the “microvioma”(good bowel bacteria) consists of billion microorganisms. Attention should be paid on behalf of the patients to the fact that prebiotics contained in food like yoghurts correspond in only a few thousand prebiotics hence they are not suitable for therapeutic use. 

In Greece among the available prebiotic pharmaceutics the only for which there are clinical laboratory studies is  Lactoleuvre®, by Uni-pharma company, that contains per cap 1.5 billion germs of the type Saccharomyces boulardii, 1.75 billion germs of the type Bifidobacterium lactis, 1.5 billion germs of the type  Lactobacillus acidophilus and half billion germs of the type Lactobacillus plantarum.

The clinical effectiveness of this pharmaceutics has been proven in two big studies on Greek patients that have been carried out by our research group in the University General Hospital ATTIKON. Recently the second study was completed, throughout which the pharmaceutics Lactoleuvre was given to people suffering from irritable bowel syndrome every day for a whole month. Τhe patients were evaluated one month after the cease of the treatment. It was found out that symptoms of constipation and abdominal pain had been seriously reduced while at least 50% of the patients reported amelioration of the quality of their life.

. 

In the 8th Pancyprian Pharmaceutical Conference held in Nicosia Hilton Park Hotel the weekend 17 and November 18, Pharmabelle participated dynamically.

The conference was organized by the Pancyprian Pharmaceutical Association and was under the auspices of Cypriot Health Minister Konstantinos Ioannou.

The aim of the conference was to highlight issues related to the daily life of the pharmacy and the new needs created in the constantly changing social and economic environment.

With his scientific and advisory role, modern pharmacist is a key element of Primary Health Care. From simple pharmaceutical advice, advice on feminine care and the cold of the child to vaccination, the modern pharmacist plays a key role in the health system and the lives of citizens and patients.

In addition to the Conference’s main scientific program, on the 18th of November, European Day Against the Misuse of Antibiotics, an open session was held for the public on “Abuse of Antibiotics and Microbial Resistance”. Also, a lecture was held on the importance of probiotics in modern therapies, by Professor Evangelos Giamarellos, sponsor of which was Uni-Pharma & Pharmabelle.

The OFET Group, founded in 1963 by pharmacist Cleon Chet uncomfortable with the logic of a dynamic Greek pharmaceutical industry that produces safe, reliable and high added value drugs.

Today, the Group’s management, along with more than 500 employees, continues the vision of its founder, harmoniously combining technology and new scientific developments, not only in Greece but also in 53 international markets.

.

The Pediatric Society of Cyprus thanked all the companies that participated in the 21st Pancyprian Pediatric Congress.

As the Scientific Society specifically points out to the participants: “Without your contribution and your strong support, the generally acknowledged success of the 21st Pancyprian Pediatric Congress of the Cyprus Pediatric Society would not be feasible.”

“For this reason, we owe a great thank you to the companies and your pharmaceutical representatives, who stood tirelessly with us last weekend, and with good mood and cooperation helped us to let the 210 delegates attend our conference, she says in her thank-you letter to the Pediatric Society.

Let us remind you that the 21st Pancyprian Pediatric Congress took place on 10 and 11 November in Limassol, Cyprus (at the GrandResort Hotel), the Pharmabelle trade company of the Tseti Pharmaceutical Group.

The Pharmabelle booth attracted a number of doctors and scientists who showed interest in the company’s pediatric formulations.

.

  

Pharmabelle, the trading company of the Tseti Pharmaceutical Group, participated at the 21st Pancyprian Pediatric Congress which held in Limassol, Cyprus on 10-11 November (at the GrandResort hotel).

The conference was organized by the Cyprus Pediatric Society, a very dynamic scientific company.

A big number of doctors and scientists visited the stand of Pharmabelle, who showed interest in the company’s pediatric medicines.

The Tseti Pharmaceutical Group was established in 1963 by the dynamic pharmacist and researcher Kleon Tsetis, with the vision of a Greek dynamic pharmaceutical industry that will produce safe, reliable and added value medicines.

The Group’s management today, with the more than 500 employees, continues the vision and the journey of its founder, combining with harmony, technology and new scientific developments. This interesting trip  continues not only in Greece but also in 53 international markets all over the world!

Pharmabelle, participated with great success in Cyprus, at the Workshop “Interactions of the Cardiovascular and Respiratory System Development and Prospects”.

The event was co-organized by the Cyprus Cardiology Society, the Thoracic Foundation and the Cyprus Pulmonary Society.

The conference was held on 2 June 2018 at the Mediterranean Beach Hotel in Limassol.

The workshop was attended by a number of physicians and specialists who had the opportunity to learn thoroughly about all new scientific data on the relationship between cardiovascular and respiratory, which is so important for the good health of the human body.

Doctors and stakeholders gave an appointment the next year again in sunny Cyprus!

Another success for Tsetis Group of Pharmaceutical Companies. More specifically, Pharmabelle, the Cyprus trading company of the group, took the first step on the journey towards Excellence with its successful participation in the International Certification scheme EFQM Committed to Excellence, demonstrating commitment and passion for Excellence.

Pharmabelle employees participated with enthusiasm and teamwork on the projects that were implemented to continuously improve business processes in key operating areas of the company.

The awarding of the Certificate took place in Athens during the ceremony “ARISTEA 2017” organized by the Hellenic Management Association. The Certificate was received by Mrs Myrto Rapti Brand Manager, and Mrs Maria Sakellli, Sales Manager.

Pharmabelle successfully participated in the 8th Cyprian Congress of Gynecology, held in Limassol on November 25-27, 2016.

Pharmabelle had a dynamic presence in the 3rd Congress of Internal Medicine, held in Nicosia on December 3-4, 2016.

Vitafix® product range won the 1st place among the products presented on the pan-European meeting of the Stamegna Network : Health Care and received the accreditation : ‘Stamegna Innovative FMCG Product of the Year 2015′!

Pharmabelle successfully participated i nthe 18th Cyprian Pediatric conference held on 21-22 November 2015 in Nicosia.

Pharmabelle attended the 7th Cyprian Pharmaceutical Conference that took place on 8,9 and 10 May in Nicosia.

It has been estimated that the conference was visited by more than 400 Cypriot pharmacists.

Pharmabelle attended the 7th Cyprian Pharmaceutical Conference that took place on 8,9 and 10 May in Nicosia.

It has been estimated that the conference was visited by more than 400 Cypriot pharmacists.